<SEC-DOCUMENT>0001178913-24-000498.txt : 20240213
<SEC-HEADER>0001178913-24-000498.hdr.sgml : 20240213
<ACCEPTANCE-DATETIME>20240213081737
ACCESSION NUMBER:		0001178913-24-000498
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20240213
FILED AS OF DATE:		20240213
DATE AS OF CHANGE:		20240213

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ELTEK LTD
		CENTRAL INDEX KEY:			0001024672
		STANDARD INDUSTRIAL CLASSIFICATION:	PRINTED CIRCUIT BOARDS [3672]
		ORGANIZATION NAME:           	04 Manufacturing
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-28884
		FILM NUMBER:		24622683

	BUSINESS ADDRESS:	
		STREET 1:		SGOOLA INDUSTRIAL ZONE
		STREET 2:		P O B 159
		CITY:			PETACH TIKVA
		STATE:			L3
		ZIP:			49101 I
		BUSINESS PHONE:		972-3-9395025

	MAIL ADDRESS:	
		STREET 1:		SGOOLA INDUSTRIAL ZONE
		STREET 2:		P O B 159
		CITY:			PETACH TIKVA
		STATE:			L3
		ZIP:			49101
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>zk2430939.htm
<DESCRIPTION>6-K
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using Broadridge PROfile 23.9.1.5178
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div>
      <div style="line-height: 1.25; background-color: rgb(255, 255, 255); font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;">
        <div style="text-align: center; line-height: 1.25;">SECURITIES AND EXCHANGE COMMISSION</div>
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">Washington, D.C. 20549</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25; background-color: rgb(255, 255, 255); font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;">
        <div style="text-align: center; line-height: 1.25;">F O R M 6-K</div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">UNDER THE SECURITIES EXCHANGE ACT OF 1934</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">For the month of February 2024</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25;">Commission file number 000-28884</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25; background-color: rgb(255, 255, 255); font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-style: normal; font-variant: normal; text-transform: none;">
        <div style="text-align: center; line-height: 1.25;"><u>Eltek Ltd.</u></div>
      </div>
      <div style="text-align: center; line-height: 1.25;">(Name of Registrant)</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25;">Sgoola Industrial Zone, Petach Tikva, Israel</div>
      <div style="text-align: center; line-height: 1.25;">(Address of Principal Executive Office)</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-indent: 36pt; line-height: 1.25; font-weight: bold;">Indicate by check mark whether the registrant files or will file annual reports under cover of Form
        20-F or Form 40-F.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">Form 20-F &#9746; Form 40-F &#9744;</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: center; line-height: 1.25;">ELTEK LTD.</div>
        <div style="text-align: center; line-height: 1.25;">EXPLANATORY NOTE</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="line-height: 1.25;">The following exhibits are attached:</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" id="z5be393c9cf244195868b06ebb8375e49" class="DSPFListTable">

            <tr style="vertical-align: top;">
              <td style="text-align: right; vertical-align: top; width: 36pt;">
                <div style="text-align: left; line-height: 1.25;"><a href="exhibit_99-1.htm">99.1</a></div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="line-height: 1.25;"><a href="exhibit_99-1.htm">Press
                      Release:<font style="font-weight: bold;">&#160;</font>Eltek Announces Pricing of Public Offering of Ordinary Shares</a></div>
              </td>
            </tr>

        </table>
      </div>
      <table cellspacing="0" cellpadding="0" id="z62a37ecad5814eac8b4582817fa2c1b2" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top;"><a href="exhibit_99-2.htm">99.2</a></td>
            <td style="width: auto; vertical-align: top;">
              <div><a href="exhibit_99-2.htm">Underwriting Agreement between Eltek Ltd. and ThinkEquity
                  LLC, as Representative of the Several Underwriters</a></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">Signature</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its
        behalf by the undersigned, thereunto duly authorized.</div>
      <div style="line-height: 1.25;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" id="z078cba20bdd34f75a8af35a058b4fbe6" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Eltek Ltd.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">(Registrant)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">By: <u>/s/ Ron Freund</u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Ron Freund</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Chief Financial Officer</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"> <br>
      </div>
      <div style="line-height: 1.25;">Dated: February 13, 2024</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
      <div style="line-height: 1.25;">&#160;</div>
    </div>
    <div> <br>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit_99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using Broadridge PROfile 23.9.1.5178
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div style="text-align: right;"> <u><font style="font-weight: bold;">Exhibit 99.1</font></u><br>
    </div>
    <div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="line-height: 1.25;"><img width="146" height="78" src="image0.jpg"></div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="line-height: 1.25; font-style: italic; font-weight: bold;">Press Release</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">Eltek Announces Pricing of Public Offering of Ordinary Shares</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">Petach Tikva, Israel, February 12, 2024 - Eltek Ltd. (NASDAQ: <u>ELTK</u>), a global manufacturer and supplier of technologically advanced solutions in the field of printed circuit boards, announced today the pricing of an underwritten public offering of 625,000 ordinary shares at a public
        offering price of $16.00 per share, for gross proceeds of $10,000,000, before deducting underwriting discounts and offering expenses. All of the ordinary shares are being sold by the Company. The offering is expected to close on February 15, 2024,
        subject to satisfaction of customary closing conditions.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">ThinkEquity is acting as sole book-running manager for the offering.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">The Company intends to use the net proceeds from this offering to strategically invest in the expansion of its production capabilities
        and for general corporate purposes including working capital.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">The securities are being offered and sold pursuant to a shelf registration statement on Form F-3 (File No. 333-266346), including a
        base prospectus, filed with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) on July 27, 2022 and declared effective on August 5, 2022. The offering will be made only by means of a written prospectus. A prospectus supplement and accompanying
        prospectus describing the terms of the offering will be filed with the SEC on its website at www.sec.gov. Copies of the prospectus supplement and the accompanying prospectus relating to the offering may also be obtained from the offices of
        ThinkEquity, 17 State Street, 41st Floor, New York, New York 10004.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Before investing in this offering, interested parties should read in their entirety the prospectus supplement and the accompanying
        prospectus and the other documents that the Company has filed with the SEC that are incorporated by reference in such prospectus supplement and the accompanying prospectus, which provide more information about the Company and such offering.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these
        securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25; font-weight: bold;">About Eltek</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Eltek &#8211; &#8220;Innovation Across the Board&#8221;, is a global manufacturer and supplier of technologically advanced solutions in the field of
        printed circuit boards (PCBs) and is an Israeli leading company in this industry. PCBs are the core circuitry of most electronic devices. Eltek specializes in the manufacture and supply of complex and high-quality PCBs, HDI, multilayered and
        flex-rigid boards for the high-end market. Eltek is ITAR compliant and has AS-9100 and NADCAP electronics certifications. Its customers include leading companies in the defense, aerospace and medical industries in Israel, the United States, Europe
        and Asia.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Eltek was founded in 1970. The Company&#8217;s headquarters, R&amp;D, production and marketing center are located in Israel. Eltek also
        operates through its subsidiary in North America and by agents and distributors in Europe, India, South Africa and South America.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">For more information, visit Eltek's web site at <u>www.nisteceltek.com</u></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25; font-weight: bold;">Forward Looking Statement</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Some of the statements included in this press release may be forward-looking statements that involve a number of risks and
        uncertainties including, but not limited to expected results in future quarters, the impact of the Coronavirus on the economy and our operations, the impact of the war and hostilities between Israel and Hamas and Israel and Hezbollah, risks in
        product and technology development and rapid technological change, product demand, the impact of competitive products and pricing, market acceptance, the sales cycle, changing economic conditions and other risk factors detailed in the Company&#8217;s
        Annual Report on Form 20-F and other filings with the United States Securities and Exchange Commission. Any forward-looking statements set forth in this press release speak only as of the date of this press release. The information found on our
        website is not incorporated by reference into this press release and is included for reference purposes only.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25; font-weight: bold;">Investor Contact</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">Ron Freund<br>
        Chief Financial Officer<br>
        <u>Investor-Contact@nisteceltek.com</u></div>
      <div style="line-height: 1.25;">+972-3-939-5023</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div>
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>exhibit_99-2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using Broadridge PROfile 23.9.1.5178
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div style="text-align: right;"> <u><font style="font-weight: bold;">Exhibit 99.2</font></u><br>
    </div>
    <div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">UNDERWRITING AGREEMENT</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">between</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">ELTEK LTD.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">and</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">THINKEQUITY LLC</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">as Representative of the Several Underwriters</div>
      <div class="BRPFPageFooter">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">ELTEK LTD.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;"><u>UNDERWRITING AGREEMENT</u></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: right; line-height: 1.25;">New York, New York<br>
        February 12, 2024</div>
      <div style="line-height: 1.25;"> <br>
      </div>
      <div style="line-height: 1.25;">ThinkEquity LLC</div>
      <div style="line-height: 1.25;">As Representative of the several Underwriters named on Schedule 1 attached hereto<br>
        17 State Street, 41<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup> Fl</div>
      <div style="line-height: 1.25;">New York, NY 10004</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">Ladies and Gentlemen:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The undersigned, Eltek Ltd., a corporation formed under the laws of the State of Israel (collectively with its subsidiaries and affiliates, including, without limitation, all
        entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of the&#160;&#8221;<font style="font-weight: bold;">Company</font>&#8221;), hereby confirms its agreement (this &#8220;<font style="font-weight: bold;">Agreement</font>&#8221;) with ThinkEquity LLC (hereinafter referred to as &#8220;you&#8221; (including its correlatives) or the &#8220;<font style="font-weight: bold;">Representative</font>&#8221;) and with the other underwriters named on <u>Schedule 1</u> hereto for
        which the Representative is acting as representative (the Representative and such other underwriters being collectively called the &#8220;<font style="font-weight: bold;">Underwriters</font>&#8221; or, individually, an &#8220;<font style="font-weight: bold;">Underwriter</font>&#8221;)



        as follows:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">1.&#160;&#160;&#160;&#160;&#160; &#160; &#160; &#160;&#160; <u>Purchase and Sale of Shares</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">1.1&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-style: italic;"><u>Firm Shares</u>.</font></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">1.1.1.&#160;&#160;&#160;&#160;&#160;&#160; <u>Nature and Purchase of Firm Shares</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On the basis of the representations and warranties herein contained, but subject to the terms and conditions herein set forth, the Company agrees to issue and sell
        to the several Underwriters, an aggregate of 625,000<font style="font-weight: bold;">&#160;</font>shares (the &#8220;<font style="font-weight: bold;">Firm Shares</font>&#8221;) of the Company&#8217;s ordinary shares, par value NIS 3.00&#160; per share (the &#8220;<font style="font-weight: bold;">Ordinary Shares</font>&#8221;).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Underwriters, severally and not jointly, agree to purchase from the Company the number of Firm Shares set forth opposite their respective names on <u>Schedule
          1</u> attached hereto and made a part hereof at a purchase price of $15.04 per Firm Share (94.0% of the per Firm Share offering price). The <font style="font-weight: bold;">Firm Shares </font>are to be offered initially to the public at the
        offering price set forth on the cover page of the Prospectus (as defined in Section 2.1.1 hereof).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">1.1.2.&#160;&#160;&#160;&#160;&#160;&#160; <u>Shares Payment and Delivery</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Delivery and payment for the Firm Shares shall be made at 10:00 a.m., Eastern time, on the second (2<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">nd</sup>) Business Day following the date hereof&#160; (or the
        third (3<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">rd</sup>) Business Day following the date hereof if the Registration Statement is declared effective after 4:01 p.m., Eastern time) or at such earlier time as shall be agreed upon by the Representative and the Company, at the offices
        of Sullivan &amp; Worcester, LLP, 1633 Broadway, 32<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">nd</sup> Floor, New York, NY 10019 (&#8220;<font style="font-weight: bold;">Representative Counsel</font>&#8221;), or at such other place (or remotely by facsimile or other electronic transmission) as
        shall be agreed upon by the Representative and the Company. The hour and date of delivery and payment for the Firm Shares is called the &#8220;Closing Date.&#8221;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%- % -%-->
      <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Payment for the Firm Shares shall be made on the Closing Date by wire transfer in Federal (same day) funds, payable to the order of the Company upon delivery of the
        certificates (in form and substance satisfactory to the Underwriters) representing the Firm Shares (or through the facilities of the Depository Trust Company (&#8220;<font style="font-weight: bold;">DTC</font>&#8221;)) for the account of the Underwriters. The
        Firm Shares shall be registered in such name or names and in such authorized denominations as the Representative may request in writing at least two (2) full Business Days prior to the Closing Date. The Company shall not be obligated to sell or
        deliver the Firm Shares except upon tender of payment by the Representative for all of the Firm Shares. The term &#8220;Business Day&#8221; means any day other than a Saturday, a Sunday or a legal holiday or a day on which banking institutions are authorized
        or obligated by law to close in New York, New York.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">1.2&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160; <font style="font-style: italic;"><u>Over-allotment Option</u>.</font></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">1.2.1.&#160;&#160;&#160;&#160;&#160; <u>Option Shares</u>. For the purposes of covering any over-allotments in connection with the distribution and sale of the Firm Shares, the Company hereby grants to
        the Underwriters an option to purchase up to 0 additional shares of Ordinary Shares (the &#8220;Over-allotment Option&#8221;). Such 0 additional shares of Ordinary Shares, the net proceeds of which will be deposited with the Company&#8217;s account, are hereinafter
        referred to as &#8220;<font style="font-weight: bold;">Option Shares</font>.&#8221;&#160; The purchase price to be paid per Option Share shall be equal to the price per Firm Share in Section 1.1.1 hereof.&#160; The Firm Shares and the Option Shares are hereinafter
        referred to together as the &#8220;Public Securities.&#8221;&#160; The Public Securities shall be issued directly by the Company and shall have the rights and privileges described in the Registration Statement, the Disclosure Package and the Prospectus.&#160; The
        offering and sale of the Public Securities is hereinafter referred to as the &#8220;Offering.&#8221;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">1.2.2.&#160;&#160;&#160;&#160;&#160; <u>Exercise of Option</u>.&#160; The Over-allotment Option granted pursuant to Section 1.2.1 hereof may be exercised by the Representative as to all (at any time) or any
        part (from time to time) of the Option Shares within 45 days after the date hereof. The Underwriters shall not be under any obligation to purchase any Option Shares prior to the exercise of the Over-allotment Option.&#160; The Over-allotment Option
        granted hereby may be exercised by the giving of oral notice to the Company from the Representative, which must be confirmed in writing by overnight mail or facsimile or other electronic transmission setting forth the number of Option Shares to be
        purchased and the date and time for delivery of and payment for the Option Shares (the&#160;&#8221;<font style="font-weight: bold;">Option Closing Date</font>&#8221;), which shall not be later than one (1) full Business Day after the date of the notice or such
        other time as shall be agreed upon by the Company and the Representative, at the offices of Representative Counsel or at such other place (including remotely by facsimile or other electronic transmission) as shall be agreed upon by the Company and
        the Representative.&#160; If such delivery and payment for the Option Shares does not occur on the Closing Date, the Option Closing Date will be as set forth in the notice.&#160; Upon exercise of the Over-allotment Option with respect to all or any portion
        of the Option Shares, subject to the terms and conditions set forth herein, (i) the Company shall become obligated to sell to the Underwriters the number of Option Shares specified in such notice and (ii) each of the Underwriters, acting severally
        and not jointly, shall purchase that portion of the total number of Option Shares then being purchased as set forth in <u>Schedule 1</u> opposite the name of such Underwriter.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">1.2.3.&#160;&#160;&#160;&#160;&#160; <u></u><u>Payment and Delivery</u>.&#160; Payment for the Option Shares shall be made on the Option Closing Date by wire transfer in Federal (same day) funds, payable to
        the order of the Company upon delivery to you of certificates (in form and substance satisfactory to the Underwriters) representing the Option Shares (or through the facilities of DTC) for the account of the Underwriters.&#160; The Option Shares shall
        be registered in such name or names and in such authorized denominations as the Representative may request in writing at least one (1) full Business Day prior to the Option Closing Date.&#160; The Company shall not be obligated to sell or deliver the
        Option Shares except upon tender of payment by the Representative for applicable Option Shares.&#160; The Option Closing Date may be simultaneous with, but not earlier than, the Closing Date; and in the event that such time and date are simultaneous
        with the Closing Date, the term &#8220;<font style="font-weight: bold;">Closing Date</font>&#8221; shall refer to the time and date of delivery of the Firm Shares and Option Shares.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 2 -</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; line-height: 1.25;">2.&#160;&#160;&#160;&#160; &#160; &#160; &#160;&#160;&#160; <u>Representations and Warranties of the Company</u>.&#160; The Company represents and warrants to the Underwriters as of the Applicable Time (as defined below), as of the Closing Date
        and as of the Option Closing Date, if any, as follows:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.1&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-style: italic;"><u>Filing of Registration Statement</u>.</font></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.1.1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Pursuant to the Securities Act</u>.&#160; The Company has filed with the U.S. Securities and Exchange Commission (the &#8220;<font style="font-weight: bold;">Commission</font>&#8221;)



        a &#8220;shelf&#8221; registration statement on Form F-3 (File No. 333-266346), including any related prospectus or prospectuses, for the registration of the Public Securities under the Securities Act, which registration statement was prepared by the Company
        in all material respects in conformity with the requirements of the Securities Act and the rules and regulations of the Commission under the Securities Act (the &#8220;<font style="font-weight: bold;">Securities Act Regulations</font>&#8221;) and contains and
        will contain all material statements that are required to be stated therein in accordance with the Securities Act and the Securities Act Regulations. Except as the context may otherwise require, such registration statement on file with the
        Commission at any given time, including any amendments thereto to such time, exhibits and schedules thereto at such time, documents filed as a part thereof or incorporated pursuant to Item 12 of Form F-3 under the Securities Act at such time and
        the documents and information otherwise deemed to be a part thereof or included therein pursuant to Rule 430B of the Securities Act Regulations (the &#8220;<font style="font-weight: bold;">Rule 430B Information</font>&#8221;) or otherwise pursuant to the
        Securities Act Regulations at such time, is referred to herein as the &#8220;<font style="font-weight: bold;">Registration Statement</font>.&#8221; The Registration Statement at the time it originally became effective is referred to herein as the &#8220;<font style="font-weight: bold;">Initial Registration Statement</font>.&#8221; If the Company files any registration statement pursuant to Rule 462(b) of the Securities Act Regulations, then after such filing, the term &#8220;Registration Statement&#8221; shall include
        such registration statement filed pursuant to Rule 462(b). The Registration Statement was declared effective by the Commission on August 5, 2022.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The prospectus in the form in which it was filed with the Commission in connection with the Initial Registration Statement is herein called the &#8220;<font style="font-weight: bold;">Base



          Prospectus</font>.&#8221;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Promptly after the execution and delivery of this Agreement, the Company will prepare and file with the Commission a final prospectus supplement to the Base Prospectus relating
        to the Public Securities and the Offering in accordance with the provisions of Rule 430B and Rule 424(b) of the Securities Act Regulations. Such final prospectus supplement (including the Base Prospectus as so supplemented), in the form filed with
        the Commission pursuant to Rule 424(b) under the Securities Act is herein called the &#8220;<font style="font-weight: bold;">Prospectus</font>.&#8221; Any reference herein to the Base Prospectus or the Prospectus shall be deemed to refer to and include the
        documents incorporated by reference therein pursuant to Item 12 of Form F-3 under the Securities Act as of the date of such prospectus.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;Applicable Time&#8221; means <font style="font-weight: bold;">5:30&#160; p.m.</font>, Eastern time, on the date of this Agreement<font style="font-weight: bold;">.</font><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Disclosure Package</font>&#8221; means any Issuer General Use Free Writing Prospectus issued at or prior to the Applicable Time and the information
        included on <u>Schedule 2-A</u> hereto, all considered together.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Issuer Free Writing Prospectus</font>&#8221; means any &#8220;issuer free writing prospectus,&#8221; as defined in Rule 433 of the Securities Act Regulations
        (&#8220;Rule 433&#8221;), including without limitation any &#8220;free writing prospectus&#8221; (as defined in Rule 405 of the Securities Act Regulations) relating to the Public Securities that is (i)&#160;required to be filed with the Commission by the Company, (ii)&#160;a &#8220;road
        show that is a written communication&#8221; within the meaning of Rule 433(d)(8)(i), whether or not required to be filed with the Commission, or (iii)&#160;exempt from filing with the Commission pursuant to Rule 433(d)(5)(i) because it contains a description
        of the Public Securities or of the Offering that does not reflect the final terms, in each case in the form filed or required to be filed with the Commission or, if not required to be filed, in the form retained in the Company&#8217;s records pursuant to
        Rule 433(g).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 3 -</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Issuer General Use Free Writing Prospectus</font>&#8221; means any Issuer Free Writing Prospectus that is intended for general distribution to
        prospective investors (other than a &#8220;<font style="font-style: italic;">bona fide</font> electronic road show,&#8221; as defined in Rule 433 (the &#8220;<font style="font-weight: bold;">Bona Fide Electronic Road Show</font>&#8221;)), as evidenced by its being
        specified in <u>Schedule 2-B</u> hereto.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Issuer Limited Use Free Writing Prospectus</font>&#8221; means any Issuer Free Writing Prospectus that is not an Issuer General Use Free Writing
        Prospectus.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.1.2.&#160;&#160;&#160;&#160;&#160; <u>Pursuant to the Exchange Act</u>.&#160; The Company has filed with the Commission a Form 8-A providing for the registration pursuant to Section 12(b) under the
        Securities Exchange Act of 1934, as amended (the &#8220;<font style="font-weight: bold;">Exchange Act</font>&#8221;), of the Ordinary Shares. The registration of the shares of Ordinary Shares under the Exchange Act has been declared effective by the Commission
        on or prior to the date hereof.&#160; The Company has taken no action designed to, or likely to have the effect of, terminating the registration of the shares of Ordinary Shares under the Exchange Act, nor has the Company received any notification that
        the Commission is contemplating terminating such registration.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.2&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160; <u>Stock Exchange Listing</u>.&#160; The Ordinary Shares&#160; are listed on the Nasdaq Capital Market (the &#8220;<font style="font-weight: bold;">Exchange</font>&#8221;) under the
        symbol &#8220;ELTK&#8221;, and the Company has taken no action designed to, or likely to have the effect of, delisting the shares of Ordinary Shares s from the Exchange, nor has the Company received any notification that the Exchange is contemplating
        terminating such listing except as described in the Registration Statement, the Disclosure Package and the Prospectus. The Company has submitted the Listing of Additional Shares Notification Form with the Exchange with respect to the Offering of
        the Public Securities.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.3&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>No Stop Orders, etc</u>.&#160; Neither the Commission nor, to the Company&#8217;s knowledge, any state regulatory authority has issued any order preventing or suspending
        the use of the Registration Statement or the Prospectus or has instituted or, to the Company&#8217;s knowledge, threatened to institute, any proceedings with respect to such an order. The Company has complied with each request (if any) from the
        Commission for additional information.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.4&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160; <u>Disclosures in Registration Statement</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.4.1.&#160;&#160;&#160;&#160;&#160;&#160; <u>Compliance with Securities Act and 10b-5 Representation</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each of the Registration Statement and any post-effective amendment thereto, at the time it became effective (including each deemed effective date with respect to
        the Underwriters pursuant to Rule 430B or otherwise under the Securities Act) complied and will comply in all material respects with the requirements of the Securities Act and the Securities Act Regulations. The conditions for use of Form F-3, set
        forth in the General Instructions thereto, including, but not limited to, General Instruction I.B.6 and other conditions related to the offer and sale of the Public Securities, have been satisfied. Each Prospectus, at the time each was or will be
        filed with the Commission, complied and will comply in all material respects with the requirements of the Securities Act and the Securities Act Regulations. Each Prospectus delivered to the Underwriters for use in connection with this Offering was
        or will be identical to the electronically transmitted copies thereof filed with the Commission pursuant to EDGAR, except to the extent permitted by Regulation S-T.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Neither the Registration Statement nor any amendment thereto, at its effective time, as of the Applicable Time, at the Closing Date or at any Option Closing Date
        (if any), contained, contains or will contain an untrue statement of a material fact or omitted, omits or will omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 4 -</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Disclosure Package, as of the Applicable Time, at the Closing Date or at any Option Closing Date (if any), did not, does not and will not include an untrue
        statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; and each Issuer Limited Use Free Writing Prospectus
        hereto does not conflict with the information contained in the Registration Statement, the Pricing Prospectus or the Prospectus, and each such Issuer Limited Use Free Writing Prospectus, as supplemented by and taken together with the Pricing
        Prospectus as of the Applicable Time, did not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not
        misleading; provided, however, that this representation and warranty shall not apply to statements made or statements omitted in reliance upon and in conformity with written information furnished to the Company with respect to the Underwriters by
        the Representative expressly for use in the Registration Statement, the Pricing Prospectus or the Prospectus or any amendment thereof or supplement thereto. The parties acknowledge and agree that such information provided by or on behalf of any
        Underwriter consists solely of the following disclosure contained in the &#8220;Underwriting&#8221; section of the Prospectus: (i) the first sentence of the subsection entitled &#8220;Underwriting Discounts and Commissions&#8221; related to concessions; (ii) the first
        paragraph under the subsection entitled &#8220;Stabilization;&#8221; and (iii) the first sentence under the subsection entitled &#8220;Passive Market Making&#8221; (the &#8220;<font style="font-weight: bold;">Underwriters&#8217; Information</font>&#8221;).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160; Neither the Prospectus nor any amendment or supplement thereto (including any prospectus wrapper), as of its issue date, at the time of any filing with the
        Commission pursuant to Rule 424(b), at the Closing Date or at any Option Closing Date, included, includes or will include an untrue statement of a material fact or omitted, omits or will omit to state a material fact necessary in order to make the
        statements therein, in the light of the circumstances under which they were made, not misleading; provided, however, that this representation and warranty shall not apply to the&#160;Underwriters&#8217; Information.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The documents incorporated by reference in the Registration Statement, the Disclosure Package and the Prospectus, when they became effective or were filed with the
        Commission, as the case may be, conformed in all material respects to the requirements of the Securities Act or the Exchange Act, as applicable, and the rules and regulations of the Commission thereunder and none of such documents contained any
        untrue statement of a material fact or omitted to state any material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading; and any further
        documents so filed and incorporated by reference in the Registration Statement, the Disclosure Package and the Prospectus, when such documents become effective or are filed with the Commission, as the case may be, will conform in all material
        respects to the requirements of the Securities Act or the Exchange Act, as applicable, and the rules and regulations of the Commission thereunder, and will not contain any untrue statement of a material fact or omit to state any material fact
        required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 5 -</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.4.2.&#160;&#160;&#160;&#160;&#160; <u>Disclosure of Agreements</u>.&#160; The agreements and documents described in the Registration Statement, the Disclosure Package and the Prospectus conform in all
        material respects to the descriptions thereof contained or incorporated by reference therein and there are no agreements or other documents required by the Securities Act and the Securities Act Regulations to be described in the Registration
        Statement, the Disclosure Package and the Prospectus or to be filed with the Commission as exhibits to the Registration Statement, or to be incorporated by reference in the Registration Statement, the Disclosure Package or the Prospectus, that have
        not been so described or filed or incorporated by reference. Each agreement or other instrument (however characterized or described) to which the Company is a party or by which it is or may be bound or affected and (i)&#160;that is referred to or
        incorporated by reference in the Registration Statement, the Disclosure Package and the Prospectus, or (ii)&#160;is material to the Company&#8217;s business, has been duly authorized and validly executed by the Company, is in full force and effect in all
        material respects and is enforceable against the Company and, to the Company&#8217;s knowledge the other parties thereto, in accordance with its terms, except (x)&#160;as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar
        laws affecting creditors&#8217; rights generally, (y)&#160;as enforceability of any indemnification or contribution provision may be limited under the federal and state securities laws, and (z)&#160;that the remedy of specific performance and injunctive and other
        forms of equitable relief may be subject to the equitable defenses and to the discretion of the court before which any proceeding therefor may be brought. None of such agreements or instruments has been assigned by the Company, and neither the
        Company nor, to the Company&#8217;s knowledge,&#160; any other party is in default thereunder and, to the Company&#8217;s knowledge, no event has occurred that, with the lapse of time or the giving of notice, or both, would constitute a default thereunder. To the
        Company&#8217;s knowledge, performance by the Company of the material provisions of such agreements or instruments will not result in a violation of any existing applicable law, rule, regulation, ordinance, judgment, order or decree of any governmental
        or regulatory agency, body, authority or court, domestic or foreign, having jurisdiction over the Company or any of its assets or businesses (each, a &#8220;<font style="font-weight: bold;">Governmental Entity</font>&#8221;), including, without limitation,
        those relating to environmental laws and regulations.&#160; Except as disclosed in the Registration Statement, the Disclosure Package and the Prospectus, the Company has no subsidiaries and has no other interest, nominal or beneficial, direct or
        indirect, in any other corporation, joint venture or other business entity.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.4.3.&#160;&#160;&#160;&#160;&#160; <u>Prior Securities Transactions</u>.&#160; Since December 31, 2021 no securities of the Company have been sold by the Company or by or on behalf of, or for the benefit
        of, any person or persons controlling, controlled by or under common control with the Company, except pursuant to Rule 144 or as disclosed in the Registration Statement and the Disclosure Package.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.4.4.&#160;&#160;&#160;&#160;&#160; <u>Regulations</u>.&#160; The disclosures in the Registration Statement, the Disclosure Package and the Prospectus concerning the effects of federal, state, local and all
        foreign regulation on the Offering and the Company&#8217;s business as currently contemplated are accurate, correct and complete in all material respects and no other such regulations are required to be disclosed in the Registration Statement, the
        Disclosure Package and the Prospectus which are not so disclosed.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.4.5.&#160;&#160;&#160;&#160;&#160;&#160; <u>No Other Distribution of Offering Materials</u>. The Company has not, directly or indirectly, distributed and will not distribute any offering material in
        connection with the Offering other than the Disclosure Package, the Prospectus and other materials, if any, permitted under the Securities Act and consistent with Section 3.2 below.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.5&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Changes After Dates in Registration Statement</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.5.1.&#160;&#160;&#160;&#160;&#160; <u>No Material Adverse Change</u>.&#160; Since the respective dates as of which information is given in the Registration Statement, the Disclosure Package and the
        Prospectus, except as otherwise specifically stated therein: (i)&#160;there has been no material adverse change in the financial position or results of operations of the Company, nor any change or development that, singularly or in the aggregate, would
        involve a material adverse change or a prospective material adverse change in or affecting the business, general affairs, management, condition (financial or otherwise), results of operations, stockholders&#8217; equity, business, assets, properties or
        prospects of the Company (a &#8220;<font style="font-weight: bold;">Material Adverse Change</font>&#8221;); (ii)&#160;there have been no material transactions entered into by the Company, other than as contemplated pursuant to this Agreement; and (iii)&#160;no officer
        or director of the Company has resigned from any position with the Company; and (iv) the Company has not sustained any material loss or interference with its business or properties from fire, explosion, flood, earthquake, hurricane, accident or
        other calamity.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 6 -</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.5.2.&#160;&#160;&#160;&#160;&#160; <u>Recent Securities Transactions, etc</u>.&#160; Subsequent to the respective dates as of which information is given in the Registration Statement, the Disclosure
        Package and the Prospectus, and except as may otherwise be indicated or contemplated herein or disclosed in the Registration Statement, the Disclosure Package and the Prospectus, the Company has not: (i)&#160;issued any securities or incurred any
        liability or obligation, direct or contingent, for borrowed money; or (ii)&#160;declared or paid any dividend or made any other distribution on or in respect to its capital stock.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.5.3.&#160;&#160;&#160;&#160;&#160; <u>Disclosure in Commission Filings</u>.&#160; Since December 31, 2020, (i) none of the Company&#8217;s filings with the Commission contained any untrue statement of a material
        fact or omitted to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; and (ii) the Company has made all filings with the Commission required under
        the Exchange Act and the rules and regulations of the Commission promulgated thereunder (the &#8220;Exchange Act Regulations&#8221;).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.6&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Independent Accountants</u>.&#160; To the knowledge of the Company, Brightman Almagor Zohar &amp; Co., a firm in the Deloitte Global Network&#160; (the &#8220;<font style="font-weight: bold;">Auditor</font>&#8221;), whose report is filed with the Commission and included or incorporated by reference in of the Registration Statement, the Disclosure Package and the Prospectus, is an independent registered public
        accounting firm as required by the Securities Act and the Securities Act Regulations and the Public Company Accounting Oversight Board. The Auditor has not, during the periods covered by the financial statements included or incorporated by
        reference in the Registration Statement, the Disclosure Package and the Prospectus, provided to the Company any non-audit services, as such term is used in Section 10A(g) of the Exchange Act.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.7&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Financial Statements, etc</u>.&#160; The financial statements, including the notes thereto and supporting schedules included or incorporated by reference in the
        Registration Statement, the Disclosure Package and the Prospectus, fairly present the financial position and the results of operations of the Company at the dates and for the periods to which they apply; and such financial statements have been
        prepared in conformity with U.S. generally accepted accounting principles (&#8220;<font style="font-weight: bold;">GAAP</font>&#8221;), consistently applied throughout the periods involved (provided that unaudited interim financial statements are subject to
        year-end audit adjustments that are not expected to be material in the aggregate and do not contain all footnotes required by GAAP); and the supporting schedules included or incorporated by reference in the Registration Statement present fairly the
        information required to be stated therein.&#160; Except as included therein, no historical or pro forma financial statements or supporting schedules are required to be included or incorporated by reference in the Registration Statement, the Disclosure
        Package or the Prospectus under the Securities Act or the Securities Act Regulations. The pro forma and pro forma as adjusted financial information and the related notes, if any, included or incorporated by reference in the Registration Statement,
        the Disclosure Package and the Prospectus have been properly compiled and prepared in accordance with the applicable requirements of the Securities Act, the Securities Act Regulations, the Exchange Act and the Exchange Act Regulations and present
        fairly the information shown therein, and the assumptions used in the preparation thereof are reasonable and the adjustments used therein are appropriate to give effect to the transactions and circumstances referred to therein.&#160; All disclosures
        contained in the Registration Statement, the Disclosure Package or the Prospectus, or incorporated or deemed incorporated by reference therein, regarding &#8220;non-GAAP financial measures&#8221; (as such term is defined by the rules and regulations of the
        Commission), if any, comply with Regulation G of the Exchange Act and Item 10 of Regulation S-K of the Securities Act, to the extent applicable. Each of the Registration Statement, the Disclosure Package and the Prospectus discloses all material
        off-balance sheet transactions, arrangements, obligations (including contingent obligations), and other relationships of the Company with unconsolidated entities or other persons that may have a material current or future effect on the Company&#8217;s
        financial condition, changes in financial condition, results of operations, liquidity, capital expenditures, capital resources, or significant components of revenues or expenses.&#160; Except as disclosed in the Registration Statement, the Disclosure
        Package and the Prospectus, (a) neither the Company nor any of its direct and indirect subsidiaries, including each entity disclosed or described in the Registration Statement, the Disclosure Package and the Prospectus as being a subsidiary of the
        Company (each, a &#8220;Subsidiary&#8221; and, collectively, the &#8220;Subsidiaries&#8221;), has incurred any material liabilities or obligations, direct or contingent, or entered into any material transactions other than in the ordinary course of business, (b) the
        Company has not declared or paid any dividends or made any distribution of any kind with respect to its capital stock except insofar as disclosed in the Prospectus&#160; (c) there has not been any change in the capital stock of the Company or any of its
        Subsidiaries, or, other than in the course of business or any grants under any stock compensation plan, and (d) there has not been any Material Adverse Change in the Company&#8217;s long-term or short-term debt.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 7 -</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.8&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Authorized Capital; Options, etc</u>.&#160; The Company had, at the date or dates indicated in the Registration Statement, the Disclosure Package and the Prospectus,
        the duly authorized, issued and outstanding capitalization as set forth therein. Based on the assumptions stated in the Registration Statement, the Disclosure Package and the Prospectus, the Company will have on the Closing Date the adjusted stock
        capitalization set forth therein. Except as set forth in, or contemplated by, the Registration Statement, the Disclosure Package and the Prospectus, on the date hereof, as of the Applicable Time and on the Closing Date and any Option Closing Date,
        there will be no stock options (except for up to 338,616 shares under the ESOP for employees and directors), warrants, or other rights to purchase or otherwise acquire any authorized, but unissued shares of Ordinary Shares of the Company or any
        security convertible or exercisable into shares of Ordinary Shares of the Company, or any contracts or commitments to issue or sell shares of Ordinary Shares or any such options, warrants, rights or convertible securities.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.9&#160;&#160;&#160; &#160; &#160;&#160;&#160;&#160; <u>Valid Issuance of Securities, etc</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.9.1.&#160;&#160;&#160;&#160;&#160; <u>Outstanding Securities</u>.&#160; All issued and outstanding securities of the Company issued prior to the transactions contemplated by this Agreement have been duly
        authorized and validly issued and are fully paid and non-assessable; the holders thereof have no rights of rescission, rights of first refusal, rights of participation or similar rights with respect thereto or put rights, and are not subject to
        personal liability by reason of being such holders; and none of such securities were issued in violation of the preemptive rights, rights of first refusal or rights of participation or similar rights of any holders of any security of the Company or
        similar contractual rights granted by the Company. The authorized shares of Ordinary Shares conform in all material respects to all statements relating thereto contained in the Registration Statement, the Disclosure Package and the Prospectus. The
        offers and sales of the outstanding shares of Ordinary Shares were at all relevant times either registered under the Securities Act and the applicable state securities or &#8220;blue sky&#8221; laws or, based in part on the representations and warranties of
        the purchasers of such Shares, exempt from such registration requirements.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.9.2.&#160;&#160;&#160;&#160;&#160; <u>Securities Sold Pursuant to this Agreement</u>.&#160; The Public Securities have been duly authorized for issuance and sale and, when issued and paid for pursuant to
        the terms of this Agreement, the Public Securities will be validly issued, fully paid and non-assessable; the holders thereof are not and will not be subject to personal liability by reason of being such holders; the Public Securities are not and
        will not be subject to the preemptive rights of any holders of any security of the Company or similar contractual rights granted by the Company; and all corporate action required to be taken for the authorization, issuance and sale of the Public
        Securities&#160; has been duly and validly taken.&#160; The Public Securities conform in all material respects to all statements with respect thereto contained in the Registration Statement, the Disclosure Package and the Prospectus.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.10&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Registration Rights of Third Parties</u>.&#160; Except as set forth in the Registration Statement, the Disclosure Package and the Prospectus, no holders of any
        securities of the Company or any rights exercisable for or convertible or exchangeable into securities of the Company have the right to require the Company to register any such securities of the Company under the Securities Act or to include any
        such securities in a registration statement to be filed by the Company.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 8 -</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.11&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Validity and Binding Effect of Agreements</u>.&#160; This Agreement has been duly and validly authorized by the Company, and, when executed and delivered, will
        constitute, the valid and binding agreements of the Company, enforceable against the Company in accordance with their respective terms, except: (i)&#160;as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws
        affecting creditors&#8217; rights generally; (ii)&#160;as enforceability of any indemnification or contribution provision may be limited under the federal and state securities laws; and (iii)&#160;that the remedy of specific performance and injunctive and other
        forms of equitable relief may be subject to the equitable defenses and to the discretion of the court before which any proceeding therefor may be brought.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.12&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>No Conflicts, etc</u>.&#160; The execution, delivery and performance by the Company of this Agreement and all ancillary documents, the consummation by the Company of
        the transactions herein and therein contemplated and the compliance by the Company with the terms hereof and thereof do not and will not, with or without the giving of notice or the lapse of time or both: (i)&#160;result in a material breach of, or
        conflict with any of the terms and provisions of, or constitute a material default under, or result in the creation, modification, termination or imposition of any lien, charge, mortgage, pledge, security interest, claim, equity, trust or other
        encumbrance, preferential arrangement or restriction of any kind whatsoever upon any portion of any property or assets of the Company pursuant to the terms of any indenture, mortgage, deed of trust, note, lease, loan agreement or any other
        agreement or instrument, license or permit to which the Company is a party or as to which any property of the Company is a party or any of its assets are bound, except as set forth in the Registration Statement, Disclosure Package and Prospectus;
        (ii)&#160;result in any violation of the provisions of the Company&#8217;s Second Amended and Restated Certificate of Incorporation, as amended (as the same may be amended or restated from time to time, the &#8220;Charter&#8221;) or the by-laws of the Company (as the
        same may be amended or restated from time to time); or (iii)&#160;violate any existing applicable law, rule, regulation, judgment, order or decree of any Governmental Entity as of the date hereof or by any foreign, federal, state or local regulatory
        authority performing functions similar to those performed by the FDA) except, with respect to (ii) and (iii) above, for any such violation of applicable law, rule, regulation, judgment, order or decree that would not reasonably be expected to
        result in, individually or in the aggregate, a Material Adverse Change.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.13&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>No Defaults; Violations</u>.&#160; No material default exists in the due performance and observance of any term, covenant or condition of any material license,
        contract, indenture, mortgage, deed of trust, note, loan or credit agreement, or any other agreement or instrument evidencing an obligation for borrowed money, or any other material agreement or instrument to which the Company is a party or by
        which the Company may be bound or to which any of the properties or assets of the Company is subject. The Company is not in violation of any term or provision of its Charter or by-laws, or in violation of any franchise, license, permit, applicable
        law, rule, regulation, judgment, order or decree of any Governmental Entity, except for any such violation that would not reasonably be expected to result in, individually or in the aggregate, a Material Adverse Change.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.14&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Corporate Power; Licenses; Consents</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.14.1.&#160;&#160;&#160; <u>Conduct of Business</u>.&#160; Except as described in the Registration Statement, the Disclosure Package and the Prospectus, the Company has all requisite corporate
        power and authority, and has all necessary consents, authorizations, approvals, registrations, orders, licenses, certificates, qualifications, registrations and permits of and from all governmental regulatory officials and bodies that it needs as
        of the date hereof to conduct its business purpose as described in the Registration Statement, the Disclosure Package and the Prospectus, except where such failure to have such consents, authorizations, approvals, registrations, orders, license,
        certificates, qualifications, registrations and permit would not reasonably be expected to result in a Material Adverse Change.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 9 -</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.14.2.&#160;&#160; <u>Transactions Contemplated Herein</u>.&#160; The Company has all corporate power and authority to enter into this Agreement and to carry out the provisions and conditions
        hereof, and all consents, authorizations, approvals, registrations, orders licenses, certificates, qualifications, registrations and permits<font style="font-weight: bold;">&#160;</font>required in connection therewith have been obtained. No consent,
        authorization or order of, and no filing with, any court, government agency or other body is required for the valid issuance, sale and delivery of the Public Securities and the consummation of the transactions and agreements contemplated by this
        Agreement and as contemplated by the Registration Statement, the Disclosure Package and the Prospectus, except (i) such consents, approvals, authorizations, orders, filings, registrations or qualifications that have already been obtained or made
        and (ii) with respect to applicable federal and state securities laws and the rules and regulations of the Exchange and Financial Industry Regulatory Authority, Inc. (&#8220;<font style="font-weight: bold;">FINRA</font>&#8221;).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.15&#160;&#160;&#160;&#160;&#160;&#160; <u>D&amp;O Questionnaires</u>.&#160; To the Company&#8217;s knowledge, all information contained in the questionnaires (the &#8220;<font style="font-weight: bold;">Questionnaires</font>&#8221;)



        completed by each of the Company&#8217;s directors and officers immediately prior to the Offering (the &#8220;<font style="font-weight: bold;">Insiders</font>&#8221;) as supplemented by all information concerning the Company&#8217;s directors, officers and principal
        stockholders as described in the Registration Statement, the Disclosure Package and the Prospectus, as well as in the Lock-Up Agreement (as defined in Section 2.25 below), provided to the Underwriters, is true and correct in all material respects
        and the Company has not become aware of any information which would cause the information disclosed in the Questionnaires to become materially inaccurate and incorrect.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.16&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Litigation; Governmental Proceedings</u>.&#160; There is no action, suit, proceeding, inquiry, arbitration, investigation, litigation or governmental proceeding
        pending or, to the Company&#8217;s knowledge, threatened against, or involving the Company, or, to the Company&#8217;s knowledge, any executive officer or director which has not been disclosed in the Registration Statement, the Disclosure Package and the
        Prospectus or in connection with the Company&#8217;s listing application for the listing of the Public Securities on the Exchange and which is required to be disclosed.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.17&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Good Standing</u>.&#160;&#160; The Company has been duly incorporated and is validly existing as a corporation and is in good standing under the laws of the State of
        Israel as of the date hereof, and is duly qualified to do business and is in good standing in each other jurisdiction in which its ownership or lease of property or the conduct of business requires such qualification, except where the failure to be
        so qualified or in good standing, singularly or in the aggregate, would not have&#160; or reasonably be expected to result in a Material Adverse Change.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.18&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Insurance</u>.&#160; The Company carries or is entitled to the benefits of insurance, with reputable insurers, in such amounts and covering such risks which the
        Company believes are adequate, including, but not limited to, directors and officers insurance coverage at least equal to $5,000,000<font style="font-style: italic;">&#160;</font>and all such insurance is in full force and effect. The Company has no
        reason to believe that it will not be able (i) to renew its existing insurance coverage as and when such policies expire or (ii) to obtain comparable coverage from similar institutions as may be necessary or appropriate to conduct its business as
        now conducted and at a cost that would not result in a Material Adverse Change.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.19&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Transactions Affecting Disclosure to FINRA</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.19.1.&#160;&#160;&#160; <u>Finder&#8217;s Fees</u>.&#160; Except as described in the Registration Statement, the Disclosure Package and the Prospectus, there are no claims, payments, arrangements,
        agreements or understandings relating to the payment of a finder&#8217;s, consulting or origination fee by the Company or any Insider with respect to the sale of the Public Securities hereunder or any other arrangements, agreements or understandings of
        the Company or, to the Company&#8217;s knowledge, any of its stockholders that may affect the Underwriters&#8217; compensation, as determined by FINRA.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 10 -</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.19.2.&#160;&#160;&#160; <u>Payments Within Twelve (12) Months</u>.&#160; Except as described in the Registration Statement, the Disclosure Package and the Prospectus, the Company has not made any
        direct or indirect payments (in cash, securities or otherwise) to: (i)&#160;any person, as a finder&#8217;s fee, consulting fee or otherwise, in consideration of such person raising capital for the Company or introducing to the Company persons who raised or
        provided capital to the Company; (ii) any FINRA member; or (iii)&#160; any person or entity that has any direct or indirect affiliation or association with any FINRA member, within the twelve (12) months prior to the date of this Agreement, other than
        the payment to the Underwriters as provided hereunder in connection with the Offering.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.19.3.&#160;&#160;&#160;&#160; <u>Use of Proceeds</u>.&#160; None of the net proceeds of the Offering will be paid by the Company to any participating FINRA member or its affiliates, except as
        specifically authorized herein.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.19.4.&#160;&#160;&#160; <u>FINRA Affiliation</u>.&#160; There is no (i) officer or director of the Company, (ii) beneficial owner of 5% or more of any class of the Company&#8217;s securities or (iii)
        beneficial owner of the Company&#8217;s unregistered equity securities which were acquired during the 180-day period immediately preceding the filing of the Registration Statement that is an affiliate or associated person of a FINRA member participating
        in the Offering (as determined in accordance with the rules and regulations of FINRA).&#160; The Company (i) does not have any material lending or other relationship with any bank or lending affiliate of any Underwriter and (ii) does not intend to use
        any of the proceeds from the sale of the Public Securities to repay any outstanding debt owed to any affiliate of any Underwriter.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.19.5.&#160;&#160;&#160;&#160; <u>Information</u>. All information provided by the Company in its, and to the Company&#8217;s knowledge, all information provided by the Company&#8217;s officers and directors
        in their FINRA questionnaire to Representative Counsel specifically for use by Representative Counsel in connection with its Public Offering System filings (and related disclosure) with FINRA is true, correct and complete in all material respects.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.20&#160;&#160;&#160;&#160; &#160; &#160;&#160; <u>Foreign Corrupt Practices Act</u>. None of the Company nor, to the Company&#8217;s knowledge, any director, officer, agent, employee or affiliate of the Company or
        any other person acting on behalf of the Company, has, directly or indirectly, (i) given or agreed to give any money, gift or similar benefit (other than legal price concessions to customers in the ordinary course of business) to any customer,
        supplier, employee or agent of a customer or supplier, or official or employee of any governmental agency or instrumentality of any government (domestic or foreign) or any political party or candidate for office (domestic or foreign) or other
        person who was, is, or may be in a position to help or hinder the business of the Company (or assist it in connection with any actual or proposed transaction) that (a) might subject the Company to any damage or penalty in any civil, criminal or
        governmental litigation or proceeding, (b) if not given in the past, might have had a Material Adverse Change; (c) if not continued in the future, might adversely affect the assets, business, operations or prospects of the Company; or (d) violated
        or is in violation of any provision of the Foreign Corrupt Practices Act (the &#8220;FCPA&#8221;) or any applicable non-U.S. anti-bribery statute or regulation; (ii) made any bribe, rebate, payoff, influence payment, kickback or other unlawful payment; or
        (iii) received notice of any investigation, proceeding or inquiry by any Governmental Entity regarding any of the matters in clauses (i) or (ii) above; and the Company has conducted its business in compliance with the FCPA in all material respects,
        and has instituted and maintains policies and procedures designed to ensure, and which are reasonably expected to ensure, that the Company will continue to comply in all material respects with the FCPA. The Company has taken reasonable steps to
        ensure that its accounting controls and procedures are sufficient to cause the Company to comply in all material respects with the FCPA.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 11 -</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.21&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;<u>Compliance with OFAC</u>. None of the Company and any of its Subsidiaries or, to the Company&#8217;s knowledge, any director, officer, agent, employee or affiliate of
        the Company and any of its Subsidiaries or any other person acting on behalf of the Company and any of its Subsidiaries, is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Department of the
        Treasury (&#8220;<font style="font-weight: bold;">OFAC</font>&#8221;), and the Company will not, directly or indirectly, use the proceeds of the Offering hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture
        partner or other person or entity, for the purpose of financing the activities of any person currently subject to any U.S. sanctions administered by OFAC.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.22&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160; <u>Forward-Looking Statements</u>. No forward-looking statement (within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act)
        contained in either the Registration Statement, Disclosure Package or Prospectus has been made or reaffirmed without a reasonable basis or has been disclosed other than in good faith.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.23&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u></u><u>Money Laundering Laws</u>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable
        financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering statutes of all jurisdictions, the rules and regulations thereunder and any related or similar
        rules, regulations or guidelines, issued, administered or enforced by any Governmental Entity (collectively, the &#8220;<font style="font-weight: bold;">Money Laundering Laws</font>&#8221;); and no action, suit or proceeding by or before any Governmental
        Entity involving the Company with respect to the Money Laundering Laws is pending or, to the best knowledge of the Company, threatened.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.24&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160; <u>Officers&#8217; Certificate</u>.&#160; Any certificate signed by any duly authorized officer of the Company and delivered to you or to Representative Counsel shall be
        deemed a representation and warranty by the Company to the Underwriters as to the matters covered thereby.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.25&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <u>Lock-Up Agreements.</u>&#160; <u>Schedule 3</u> hereto contains a complete and accurate list of the Company&#8217;s executive officers and&#160; directors and each owner of
        the Company&#8217;s outstanding shares of Ordinary Shares (or securities convertible into or exercisable for shares of Ordinary Shares) who will be subject to the Lock-Up Agreement (as defined below) (collectively, the &#8220;<font style="font-weight: bold;">Lock-Up



          Parties</font>&#8221;).&#160; The Company has caused each of the Lock-Up Parties to deliver to the Representative an executed Lock-Up Agreement, in the form attached hereto as <u>Exhibit A</u> (the &#8220;<font style="font-weight: bold;">Lock-Up Agreement</font>&#8221;),



        prior to the execution of this Agreement.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.26&#160;&#160; &#160; &#160;&#160;&#160;&#160;&#160; <u>Subsidiaries</u>.&#160; All direct and indirect Subsidiaries of the Company are duly organized and in good standing under the laws of the place of organization or
        incorporation, and each Subsidiary is in good standing in each jurisdiction in which its ownership or lease of property or the conduct of business requires such qualification, except where the failure to qualify would not have a material adverse
        effect on the assets, business or operations of the Company taken as a whole.&#160; The Company&#8217;s ownership and control of each Subsidiary is as described in the Registration Statement, the Disclosure Package and the Prospectus.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.27&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160; <u>Related Party Transactions</u>.&#160; There are no business relationships or related party transactions involving the Company or any other person required to be
        described in the Registration Statement, the Disclosure Package and the Prospectus that have not been described as required.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 12 -</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.28&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>No Relationships with Customers and Suppliers</u>. No relationship, direct or indirect, exists between or among the Company on the one hand, and the directors,
        officers, 5% or greater stockholders, customers or suppliers of the Company or any of the Company&#8217;s affiliates on the other hand, which is required to be described in the Disclosure Package and the Prospectus or a document incorporated by reference
        therein and which is not so described.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.29&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>No Unconsolidated Entities</u>. There are no transactions, arrangements or other relationships between and/or among the Company, any of its affiliates (as such
        term is defined in Rule 405 of the Securities Act) and any unconsolidated entity, including, but not limited to, any structured finance, special purpose or limited purpose entity that could reasonably be expected to materially affect the Company&#8217;s
        liquidity or the availability of or requirements for its capital resources required to be described in the Disclosure Package and the Prospectus or a document incorporated by reference therein which have not been described as required</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.30&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Board of Directors</u>.&#160; The Board of Directors of the Company is comprised of the persons disclosed in the Registration Statement, the Disclosure Package and
        the Prospectus. The qualifications of the persons serving as board members and the overall composition of the board comply with the Exchange Act, the Exchange Act Regulations, the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder (the
        &#8220;<font style="font-weight: bold;">Sarbanes-Oxley Act</font>&#8221;) applicable to the Company and the listing rules of the Exchange.&#160; At least one member of the Audit Committee of the Board of Directors of the Company qualifies as an &#8220;audit committee
        financial expert,&#8221; as such term is defined under Regulation S-K and the listing rules of the Exchange.&#160; In addition, at least a majority of the persons serving on the Board of Directors qualify as &#8220;independent,&#8221; as defined under the listing rules
        of the Exchange.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.31&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Sarbanes-Oxley Compliance</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.31.1.&#160;&#160;&#160; <u>Disclosure Controls</u>.&#160; The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under
        the Exchange Act Regulations and such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company&#8217;s
        Exchange Act filings and other public disclosure documents.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.31.2.&#160;&#160;&#160;&#160; <u>Compliance</u>.&#160; The Company is, or at the Applicable Time and on the Closing Date will be, in material compliance with the provisions of the Sarbanes-Oxley Act
        applicable to it, and has implemented or will implement such programs and taken reasonable steps to ensure the Company&#8217;s future compliance (not later than the relevant statutory and regulatory deadlines therefor) with all of the material provisions
        of the Sarbanes-Oxley Act.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.31.3.&#160;&#160;&#160; <u>Accounting Controls</u>. The Company and its Subsidiaries maintain systems of &#8220;internal control over financial reporting&#8221; (as defined under Rules 13a-15 and 15d-15
        under the Exchange Act Regulations) that comply with the requirements of the Exchange Act and have been designed by, or under the supervision of, their respective principal executive and principal financial officers, or persons performing similar
        functions, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP, including, but not limited to, internal accounting controls
        sufficient to provide reasonable assurance that (i) transactions are executed in accordance with management&#8217;s general or specific authorizations; (ii) transactions are recorded as necessary to permit preparation of financial statements in
        conformity with GAAP and to maintain asset accountability; (iii) access to assets is permitted only in accordance with management&#8217;s general or specific authorization; and (iv) the recorded accountability for assets is compared with the existing
        assets at reasonable intervals and appropriate action is taken with respect to any differences. Except as disclosed in the Registration Statement, the Disclosure Package and the Prospectus, the Company is not aware of any material weaknesses in its
        internal controls.&#160; The Company&#8217;s auditors and the Audit Committee of the Board of Directors of the Company have been advised of: (i) all significant deficiencies and material weaknesses in the design or operation of internal controls over
        financial reporting which are known to the Company&#8217;s management and that have adversely affected or are reasonably likely to adversely affect the Company&#8217;s ability to record, process, summarize and report financial information; and (ii) any fraud
        known to the Company&#8217;s management, whether or not material, that involves management or other employees who have a significant role in the Company&#8217;s internal controls over financial reporting.&#160; Since the date of the latest audited financial
        statements included in the Disclosure Package, there has been no change in the Company&#8217;s internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company&#8217;s internal control over
        financial reporting.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 13 -</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.32&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>No Investment Company Status</u>.&#160; The Company is not and, after giving effect to the Offering and the application of the proceeds thereof as described in the
        Registration Statement, the Disclosure Package and the Prospectus, will not be, required to register as an &#8220;investment company,&#8221; as defined in the Investment Company Act of 1940, as amended.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.33&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>No Labor Disputes</u>.&#160; Except as disclosed in the Registration Statement, the Disclosure Package and the Prospectus, no labor dispute with the employees of the
        Company or any of its Subsidiaries exists or, to the knowledge of the Company, is imminent.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.34&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Intellectual Property Rights</u>.&#160; The Company and each of its Subsidiaries owns or possesses or has valid rights to use all patents, patent applications,
        trademarks, service marks, trade names, trademark registrations, service mark registrations, copyrights, licenses, inventions, trade secrets and similar rights (&#8220;<font style="font-weight: bold;">Intellectual Property Rights</font>&#8221;) necessary for
        the conduct of the business of the Company and its Subsidiaries as currently carried on and as described in the Registration Statement, the Disclosure Package and the Prospectus.&#160; To the knowledge of the Company, no action or use by the Company or
        any of its Subsidiaries necessary for the conduct of its business as currently carried on and as described in the Registration Statement and the Prospectus will involve or give rise to any infringement of, or license or similar fees for, any
        Intellectual Property Rights of others.&#160; Neither the Company nor any of its Subsidiaries has received any notice alleging any such infringement of, license or similar fees for, or conflict with any asserted Intellectual Property Rights of others.
        Except as would not reasonably be expected to result, individually or in the aggregate, in a Material Adverse Change (A) to the knowledge of the Company, there is no infringement, misappropriation or violation by third parties of any of the
        Intellectual Property Rights owned by the Company; (B) there is no pending or, to the knowledge of the Company, threatened action, suit, proceeding or claim by others challenging the rights of the Company in or to any such Intellectual Property
        Rights, and the Company is unaware of any facts which would form a reasonable basis for any such claim, that would, individually or in the aggregate, together with any other claims in this Section 2.34, reasonably be expected to result in a
        Material Adverse Change; (C) the Intellectual Property Rights owned by the Company and, to the knowledge of the Company, the Intellectual Property Rights licensed to the Company have not been adjudged by a court of competent jurisdiction invalid or
        unenforceable, in whole or in part, and there is no pending or, to the Company&#8217;s knowledge, threatened action, suit, proceeding or claim by others challenging the validity or scope of any such Intellectual Property Rights, and the Company is
        unaware of any facts which would form a reasonable basis for any such claim that would, individually or in the aggregate, together with any other claims in this Section 2.34, reasonably be expected to result in a Material Adverse Change; (D) there
        is no pending or, to the Company&#8217;s knowledge, threatened action, suit, proceeding or claim by others that the Company infringes, misappropriates or otherwise violates any Intellectual Property Rights or other proprietary rights of others, the
        Company has not received any written notice of such claim and the Company is unaware of any other facts which would form a reasonable basis for any such claim that would, individually or in the aggregate, together with any other claims in this
        Section 2.34, reasonably be expected to result in a Material Adverse Change; and (E) to the Company&#8217;s knowledge, no employee of the Company is in or has ever been in violation in any material respect of any term of any employment contract, patent
        disclosure agreement, invention assignment agreement, non-competition agreement, non-solicitation agreement, nondisclosure agreement or any restrictive covenant to or with a former employer where the basis of such violation relates to such
        employee&#8217;s employment with the Company, or actions undertaken by the employee while employed with the Company and could reasonably be expected to result, individually or in the aggregate, in a Material Adverse Change. To the Company&#8217;s knowledge,
        all material technical information developed by and belonging to the Company which has not been patented or disclosed in a patent application has been kept confidential. The Company is not a party to or bound by any options, licenses or agreements
        with respect to the Intellectual Property Rights of any other person or entity that are required to be set forth in the Registration Statement, the Disclosure Package and the Prospectus and are not described therein. The Registration Statement, the
        Disclosure Package and the Prospectus contain in all material respects the same description of the matters set forth in the preceding sentence. None of the technology employed by the Company has been obtained or is being used by the Company in
        violation of any contractual obligation binding on the Company or any of its Subsidiaries or, to the Company&#8217;s knowledge, any of its officers, directors or employees, or otherwise in violation of the rights of any persons.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 14 -</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">To the Company&#8217;s knowledge, all licenses for the use of the Intellectual Property described in the Registration Statement, the Disclosure Package and the Prospectus are in full
        force and effect in all material respects and are enforceable by the Company and, to the Company&#8217;s knowledge, the other parties thereto, in accordance with their terms, except (x) as such enforceability may be limited by bankruptcy, insolvency,
        reorganization or similar laws affecting creditors&#8217; rights generally, (y) as enforceability of any indemnification or contribution provision may be limited under the federal and state securities laws, and (z) that the remedy of specific performance
        and injunctive and other forms of equitable relief may be subject to the equitable defenses and to the discretion of the court before which any proceeding therefor may be brought. None of such agreements or instruments has been assigned by the
        Company, and the Company, has no knowledge, that any other party is in default thereunder and no event has occurred that, with the lapse of time or the giving of notice, or both, would constitute a default thereunder.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.35&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Taxes</u>.&#160; Each of the Company and its Subsidiaries has filed all returns (as hereinafter defined) required to be filed with taxing authorities prior to the
        date hereof or has duly obtained extensions of time for the filing thereof.&#160; Each of the Company and its Subsidiaries has paid all taxes (as hereinafter defined) shown as due on such returns that were filed and has paid all taxes imposed on or
        assessed against the Company or such respective Subsidiary.&#160; The provisions for taxes payable, if any, shown on the financial statements filed with or as part of the Registration Statement are sufficient for all accrued and unpaid taxes, whether or
        not disputed, and for all periods to and including the dates of such consolidated financial statements.&#160; Except as disclosed in writing to the Underwriters, (i) no issues have been raised (and are currently pending) by any taxing authority in
        connection with any of the returns or taxes asserted as due from the Company or its Subsidiaries, and (ii) no waivers of statutes of limitation with respect to the returns or collection of taxes have been given by or requested from the Company or
        its Subsidiaries.&#160; The term &#8220;taxes&#8221; means all federal, state, local, foreign and other net income, gross income, gross receipts, sales, use, ad valorem, transfer, franchise, profits, license, lease, service, service use, withholding, payroll,
        employment, excise, severance, stamp, occupation, premium, property, windfall profits, customs, duties or other taxes, fees, assessments or charges of any kind whatever, together with any interest and any penalties, additions to tax or additional
        amounts with respect thereto.&#160; The term &#8220;returns&#8221; means all returns, declarations, reports, statements and other documents required to be filed in respect to taxes.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.36&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>ERISA Compliance</u>.&#160; The Company and any &#8220;employee benefit plan&#8221; (as defined under the Employee Retirement Income Security Act of 1974, as amended, and the
        regulations and published interpretations thereunder (collectively, &#8220;<font style="font-weight: bold;">ERISA</font>&#8221;)) established or maintained by the Company or its &#8220;ERISA Affiliates&#8221; (as defined below) are in compliance in all material respects
        with ERISA. &#8220;ERISA Affiliate&#8221; means, with respect to the Company, any member of any group of organizations described in Sections 414(b),(c),(m) or (o) of the Internal Revenue Code of 1986, as amended, and the regulations and published
        interpretations thereunder (the &#8220;Code&#8221;) of which the Company is a member. No &#8220;reportable event&#8221; (as defined under ERISA) has occurred or is reasonably expected to occur with respect to any &#8220;employee benefit plan&#8221; established or maintained by the
        Company or any of its ERISA Affiliates. No &#8220;employee benefit plan&#8221; established or maintained by the Company or any of its ERISA Affiliates, if such &#8220;employee benefit plan&#8221; were terminated, would have any &#8220;amount of unfunded benefit liabilities&#8221; (as
        defined under ERISA). Neither the Company, nor any of its ERISA Affiliates has incurred or reasonably expects to incur any material liability under (i) Title IV of ERISA with respect to termination of, or withdrawal from, any &#8220;employee benefit
        plan&#8221; or (ii) Sections 412, 4971, 4975 or 4980B of the Code. Each &#8220;employee benefit plan&#8221; established or maintained by the Company, or any of its ERISA Affiliates that is intended to be qualified under Section 401(a) of the Code is so qualified
        and, to the knowledge of the Company, nothing has occurred, whether by action or failure to act, which would cause the loss of such qualification.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 15 -</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.37&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Compliance with Laws</u>.&#160; Except as disclosed in the Registration Statement, the Disclosure Package and the Prospectus, the Company: (A) is and at all times has
        been in compliance with all statutes, rules, regulations, ordinances, judgments, orders and decrees of all Governmental Entities applicable to the Company&#8217;s business (&#8220;<font style="font-weight: bold;">Applicable</font>&#160;<font style="font-weight: bold;">Laws</font>&#8221;), except as could not, individually or in the aggregate, reasonably be expected to result in or have a Material Adverse Change; (B) has not received any warning letter, untitled letter or other correspondence or notice from
        any other Governmental Entity alleging or asserting noncompliance with any Applicable Laws or any licenses, consents, certificates, approvals, clearances, authorizations, permits, orders and supplements or amendments thereto required by any such
        Applicable Laws (&#8220;<font style="font-weight: bold;">Authorizations</font>&#8221;); (C) possesses all material Authorizations and such Authorizations are valid and in full force and effect and are not in material violation of any term of any such
        Authorizations; (D) has not received notice of any claim, action, suit, litigation, proceeding, hearing, enforcement, investigation, inquiry, arbitration or other action from any Governmental Entity or third party alleging that any product
        operation or activity is in violation of any Applicable Laws or Authorizations and has no knowledge that any such Governmental Entity or third party is considering any such claim, litigation, arbitration, action, suit, litigation proceeding,
        hearing, enforcement, investigation, inquiry, arbitration or other action; (E) has not received notice that any Governmental Entity has taken, is taking or intends to take action to limit, suspend, modify or revoke any Authorizations and has no
        knowledge that any such Governmental Entity considering such action; (F) has filed, obtained, maintained or submitted all material reports, documents, forms, filings, notices, applications, records, claims, submissions and supplements or amendments
        as required by any Applicable Laws or Authorizations and that all such reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments were complete and correct on the date filed (or were corrected or
        supplemented by a subsequent submission).;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.38&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Ineligible Issuer</u>.&#160; At the time of filing the Registration Statement and any post-effective amendment thereto, at the time of effectiveness of the
        Registration Statement and any amendment thereto, at the earliest time thereafter that the Company or another offering participant made a bona fide offer (within the meaning of Rule 164(h)(2) of the Securities Act Regulations) of the Public
        Securities and at the date hereof, the Company was not and is not an &#8220;ineligible issuer,&#8221; as defined in Rule 405, without taking account of any determination by the Commission pursuant to Rule 405 that it is not necessary that the Company be
        considered an ineligible issuer.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.39&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Environmental Laws</u>.&#160; Except as disclosed in the Registration Statement, the Disclosure Package and the Prospectus, the Company and its Subsidiaries are in
        compliance with all foreign, federal, state and local rules, laws and regulations relating to the use, treatment, storage and disposal of hazardous or toxic substances or waste and protection of health and safety or the environment which are
        applicable to their businesses (&#8220;<font style="font-weight: bold;">Environmental Laws</font>&#8221;), except where the failure to comply would not, singularly or in the aggregate, result in a Material Adverse Change. Except as disclosed in the
        Registration Statement, the Disclosure Package and the Prospectus, there has been no storage, generation, transportation, handling, treatment, disposal, discharge, emission, or other release of any kind of toxic or other wastes or other hazardous
        substances by, due to, or caused by the Company or any of its Subsidiaries (or, to the Company&#8217;s knowledge, any other entity for whose acts or omissions the Company or any of its Subsidiaries is or may otherwise be liable) upon any of the property
        now or previously owned or leased by the Company or any of its Subsidiaries , or upon any other property, in violation of any law, statute, ordinance, rule, regulation, order, judgment, decree or permit or which would, under any law, statute,
        ordinance, rule (including rule of common law), regulation, order, judgment, decree or permit, give rise to any liability; and there has been no disposal, discharge, emission or other release of any kind onto such property or into the environment
        surrounding such property of any toxic or other wastes or other hazardous substances with respect to which the Company has knowledge.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 16 -</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.40&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Real Property</u>.&#160; Except as set forth in the Registration Statement, the Disclosure Package and the Prospectus, the Company and each of its Subsidiaries have
        good and marketable title in fee simple to, or have valid rights to lease or otherwise use, all items of real or personal property which are material to the business of the Company and its Subsidiaries taken as a whole, in each case free and clear
        of all liens, encumbrances, security interests, claims and defects that do not, singly or in the aggregate, materially affect the value of such property and do not interfere with the use made and proposed to be made of such property by the Company
        or any of its Subsidiaries; and all of the leases and subleases material to the business of the Company and its subsidiaries, considered as one enterprise, and under which the Company or any of its Subsidiaries holds properties described in the
        Registration Statement, the Disclosure Package and the Prospectus, are in full force and effect, and neither the Company nor any Subsidiary has received any notice of any material claim of any sort that has been asserted by anyone adverse to the
        rights of the Company or any Subsidiary under any of the leases or subleases mentioned above, or affecting or questioning the rights of the Company or such Subsidiary to the continued possession of the leased or subleased premises under any such
        lease or sublease.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.41&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Contracts Affecting Capital</u>.&#160; There are no transactions, arrangements or other relationships between and/or among the Company, any of its affiliates (as such
        term is defined in Rule 405 of the Securities Act Regulations) and any unconsolidated entity, including, but not limited to, any structured finance, special purpose or limited purpose entity that could reasonably be expected to materially affect
        the Company&#8217;s or any of its Subsidiaries&#8217; liquidity or the availability of or requirements for their capital resources required to be described or incorporated by reference in the Registration Statement, the Disclosure Package and the Prospectus
        which have not been described or incorporated by reference as required.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.42&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Loans to Directors or Officers</u>.&#160; There are no outstanding loans, advances (except normal advances for business expenses in the ordinary course of business)
        or guarantees or indebtedness by the Company or its Subsidiaries to or for the benefit of any of the officers or directors of the Company, its Subsidiaries or any of their respective family members, except as disclosed in the Registration
        Statement, the Disclosure Package and the Prospectus.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.43&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Ineligible Issu</u>er.&#160;&#160; At the time of filing the Registration Statement and any post-effective amendment thereto, at the time of effectiveness of the
        Registration Statement and any amendment thereto, at the earliest time thereafter that the Company or another offering participant made a bona fide offer (within the meaning of Rule 164(h)(2) of the Securities Act Regulations) of the Public
        Securities and at the date hereof, the Company was not and is not an &#8220;ineligible issuer,&#8221; as defined in Rule 405, without taking account of any determination by the Commission pursuant to Rule 405 that it is not necessary that the Company be
        considered an ineligible issuer.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 17 -</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.44&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Industry Data</u>.&#160; The statistical and market-related data included in each of the Registration Statement, the Disclosure Package and the Prospectus are based
        on or derived from sources that the Company reasonably and in good faith believes are reliable and accurate or represent the Company&#8217;s good faith estimates that are made on the basis of data derived from such sources.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.45&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Margin Securities</u>.&#160; The Company owns no &#8220;margin securities&#8221; as that term is defined in Regulation U of the Board of Governors of the Federal Reserve System
        (the &#8220;Federal Reserve Board&#8221;), and none of the proceeds of Offering will be used, directly or indirectly, for the purpose of purchasing or carrying any margin security, for the purpose of reducing or retiring any indebtedness which was originally
        incurred to purchase or carry any margin security or for any other purpose which might cause any of the shares of Ordinary Shares to be considered a &#8220;purpose credit&#8221; within the meanings of Regulation T, U or X of the Federal Reserve Board.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.46&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Exchange Act Reports</u>.&#160; The Company has filed in a timely manner all reports required to be filed pursuant to Sections 13(a), 13(e), 14 and 15(d) of the
        Exchange Act during the preceding 12 months (except to the extent that Section 15(d) requires reports to be filed pursuant to Sections 13(d) and 13(g) of the Exchange Act, which shall be governed by the next clause of this sentence); and the
        Company has filed in a timely manner all reports required to be filed pursuant to Sections 13(d) and 13(g) of the Exchange Act since December 31, 2020, except where the failure to timely file could not reasonably be expected, individually or in the
        aggregate, to have a Material Adverse Change.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.47&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Minute Books</u>.&#160; The minute books of the Company have been made available to the Underwriters and Representative Counsel, and such books (i) contain a complete
        summary of all meetings and actions of the board of directors (including each board committee) and stockholders of the Company and each Subsidiary (or analogous governing bodies and interest holders, as applicable), and since January 2022&#160; through
        the date of the latest meeting and action, and (ii) accurately in all material respects reflect all transactions referred to in such minutes.&#160; There are no material transactions, agreements, dispositions or other actions of the Company and each
        Subsidiary that are not properly approved and/or accurately and fairly recorded (if required to be so recorded) in the minute books of the Company or its Subsidiary, as applicable.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.48&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Integration</u>. Neither the Company, nor any of its affiliates, nor any person acting on its or their behalf has, directly or indirectly, made any offers or
        sales of any security or solicited any offers to buy any security, under circumstances that would cause the Offering to be integrated with prior offerings by the Company for purposes of the Securities Act that would require the registration of any
        such securities under the Securities Act.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.49&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>No Stabilization</u>.&#160; Neither the Company nor, to its knowledge, any of its employees, directors or stockholders (without the consent of the Representative) has
        taken or shall take, directly or indirectly, any action designed to or that has constituted or that might reasonably be expected to cause or result in, under Regulation M of the Exchange Act, or otherwise, stabilization or manipulation of the price
        of any security of the Company to facilitate the sale or resale of the Public Securities.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.50&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Confidentiality and Non-Competition</u>. To the Company&#8217;s knowledge, no director, officer, key employee or consultant of the Company is subject to any
        confidentiality, non-disclosure, non-competition agreement or non-solicitation agreement with any employer or prior employer that could reasonably be expected to materially affect his ability to be and act in his respective capacity of the Company
        or be expected to result in a Material Adverse Change.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 18 -</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.51&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u></u><u>Testing-the-Waters Communications</u>.&#160; The Company has not (i) alone engaged in any Testing-the-Waters Communications, other than Testing-the-Waters
        Communications with the written consent of the Representative and with entities that are qualified institutional buyers within the meaning of Rule 144A under the Securities Act or institutions that are accredited investors within the meaning of
        Rule 501 under the Securities Act and (ii) authorized anyone other than the Representative to engage in Testing-the-Waters Communications.&#160; The Company confirms that the Representative has been authorized to act on its behalf in undertaking
        Testing-the-Waters Communications.&#160; The Company has not distributed any Written Testing-the-Waters Communications other than those listed on <u>Schedule 2-C</u> hereto.&#160; &#8220;Written Testing-the-Waters Communication&#8221; means any Testing-the-Waters
        Communication that is a written communication within the meaning of Rule 405 under the Securities Act.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">2.52&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Electronic Road Show</u>.&#160; The Company has made available a Bona Fide Electronic Road Show in compliance with Rule&#160;433(d)(8)(ii) of the Securities Act
        Regulations such that no filing of any &#8220;road show&#8221; (as defined in Rule&#160;433(h) of the Securities Act Regulations) is required in connection with the Offering.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Covenants of the Company</u>.&#160; The Company covenants and agrees as follows:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">3.1&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>Amendments to Registration Statement</u>.&#160; The Company shall deliver to the Representative, prior to filing, any amendment or supplement to the Registration
        Statement, Disclosure Package or Prospectus proposed to be filed after the date hereof and not file any such amendment or supplement to which the Representative shall reasonably object in writing.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">3.2&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Federal Securities Laws</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">3.2.1.&#160;&#160;&#160;&#160;&#160;&#160; <u>Compliance</u>.&#160; The Company, subject to Section 3.2.2, shall comply with the requirements of Rule 424(b) and Rule 430B of the Securities Act Regulations, and
        will notify the Representative promptly, and confirm the notice in writing, (i) when any post-effective amendment to the Registration Statement or any amendment or supplement to the Disclosure Package or the Prospectus shall have been filed and
        when any post-effective amendment to the Registration Statement shall become effective; (ii) of the receipt of any comments from the Commission; (iii) of any request by the Commission for any amendment to the Registration Statement or any amendment
        or supplement to the Disclosure Package or the Prospectus or for additional information; (iv) of the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement or any post-effective amendment or of any
        order preventing or suspending the use of the Disclosure Package or the Prospectus, or of the suspension of the qualification of the Public Securities for offering or sale in any jurisdiction, or of the initiation or threatening of any proceedings
        for any of such purposes or of any examination pursuant to Section 8(d) or 8(e) of the Securities Act concerning the Registration Statement; and (v) if the Company becomes the subject of a proceeding under Section 8A of the Securities Act in
        connection with the Offering of the Public Securities.The Company shall effect all filings required under Rule 424(b) of the Securities Act Regulations, in the manner and within the time period required by Rule 424(b) (without reliance on Rule
        424(b)(8)), and shall take such steps as it deems necessary to ascertain promptly whether the form of prospectus transmitted for filing under Rule 424(b) was received for filing by the Commission and, in the event that it was not, it will promptly
        file such prospectus. The Company shall use its best efforts to prevent the issuance of any stop order, prevention or suspension and, if any such order is issued, to obtain the lifting thereof at the earliest possible moment.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 19 -</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">3.2.2.&#160;&#160;&#160;&#160;&#160;&#160; <u>Continued Compliance</u>.&#160; The Company shall comply with the Securities Act, the Securities Act Regulations, the Exchange Act and the Exchange Act Regulations so
        as to permit the completion of the distribution of the Public Securities as contemplated in this Agreement and in the Registration Statement, the Disclosure Package and the Prospectus. If at any time when a prospectus relating to the Public
        Securities is (or, but for the exception afforded by Rule 172 of the Securities Act Regulations (&#8220;<font style="font-weight: bold;">Rule 172</font>&#8221;), would be) required by the Securities Act to be delivered in connection with sales of the Public
        Securities, any event shall occur or condition shall exist as a result of which it is necessary, in the opinion of counsel for the Underwriters or for the Company, to (i)&#160;amend the Registration Statement in order that the Registration Statement
        will not include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading; (ii)&#160;amend or supplement the Disclosure Package or the Prospectus in
        order that the Disclosure Package or the Prospectus, as the case may be, will not include any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein not misleading in the light of the
        circumstances existing at the time it is delivered to a purchaser or (iii)&#160;amend the Registration Statement or amend or supplement the Disclosure Package or the Prospectus, as the case may be, in order to comply with the requirements of the
        Securities Act or the Securities Act Regulations, the Company will promptly (A)&#160;give the Representative notice of such event; (B)&#160;prepare any amendment or supplement as may be necessary to correct such statement or omission or to make the
        Registration Statement, the Disclosure Package or the Prospectus comply with such requirements and, a reasonable amount of time prior to any proposed filing or use, furnish the Representative with copies of any such amendment or supplement and
        (C)&#160;file with the Commission any such amendment or supplement; provided, however, that the Company shall not file or use any such amendment or supplement to which the Representative or counsel for the Underwriters shall reasonably object. The
        Company will furnish to the Underwriters such number of copies of such amendment or supplement as the Underwriters may reasonably request. The Company has given the Representative notice of any filings made pursuant to the Exchange Act or the
        Exchange Act Regulations within 48 hours prior to the Applicable Time.&#160; The Company shall give the Representative notice of its intention to make any such filing from the Applicable Time until the later of the Closing Date and the exercise in full
        or expiration of the Over-allotment Option specified in Section 1.2 hereof and will furnish the Representative with copies of the related document(s) a reasonable amount of time prior to such proposed filing, as the case may be, and will not file
        or use any such document to which the Representative or counsel for the Underwriters shall reasonably object.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">3.2.3.&#160;&#160;&#160;&#160;&#160; <u>Exchange Act Registration</u>.&#160; For a period of&#160; three (3) years after the date of this Agreement, the Company shall use its best efforts to maintain the
        registration of the shares of Ordinary Shares under the Exchange Act. The Company shall not deregister the shares of Ordinary Shares under the Exchange Act without the prior written consent of the Representative.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">3.2.4.&#160;&#160;&#160;&#160;&#160;&#160; <u>Free Writing Prospectuses</u>.&#160; The Company agrees that, unless it obtains the prior written consent of the Representative, it shall not make any offer relating
        to the Public Securities that would constitute an Issuer Free Writing Prospectus or that would otherwise constitute a &#8220;free writing prospectus,&#8221; or a portion thereof, required to be filed by the Company with the Commission or retained by the
        Company under Rule 433; provided, however, that the Representative shall be deemed to have consented to each Issuer General Use Free Writing Prospectus hereto and any &#8220;road show that is a written communication&#8221; within the meaning of Rule
        433(d)(8)(i) that has been reviewed by the Representative. The Company represents that it has treated or agrees that it will treat each such free writing prospectus consented to, or deemed consented to, by the Underwriters as an &#8220;issuer free
        writing prospectus,&#8221; as defined in Rule 433, and that it has complied and will comply with the applicable requirements of Rule 433 with respect thereto, including timely filing with the Commission where required, legending and record keeping. If at
        any time following issuance of an Issuer Free Writing Prospectus there occurred or occurs an event or development as a result of which such Issuer Free Writing Prospectus conflicted or would conflict with the information contained in the
        Registration Statement or included or would include an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances existing at that
        subsequent time, not misleading, the Company will promptly notify the Underwriters and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement or omission.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 20 -</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">3.2.5.&#160;&#160;&#160;&#160;&#160; <u>Testing-the-Waters Communications</u>. If at any time following the distribution of any Written Testing-the-Waters Communication there occurred or occurs an event
        or development as a result of which such Written Testing-the-Waters Communication included or would include an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order to make the statements therein,
        in the light of the circumstances existing at that subsequent time, not misleading, the Company shall promptly notify the Representative and shall promptly amend or supplement, at its own expense, such Written Testing-the-Waters Communication to
        eliminate or correct such untrue statement or omission.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">3.3&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <u>Delivery to the Underwriters of Registration Statements</u>.&#160; The Company has delivered or made available or shall deliver or make available to the
        Representative and counsel for the Representative, without charge, signed copies of the Registration Statement as originally filed and each amendment thereto (including exhibits filed therewith or incorporated by reference therein and documents
        incorporated or deemed to be incorporated by reference therein) and signed copies of all consents and certificates of experts, and will also deliver to the Underwriters, without charge, a conformed copy of the Registration Statement as originally
        filed and each amendment thereto (without exhibits) for each of the Underwriters. The copies of the Registration Statement and each amendment thereto furnished to the Underwriters will be identical to the electronically transmitted copies thereof
        filed with the Commission pursuant to EDGAR, except to the extent permitted by Regulation S-T.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">3.4&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Delivery to the Underwriters of Prospectuses</u>.&#160; The Company has delivered or made available or will deliver or make available to each Underwriter, without
        charge, as many copies of each Prospectus as such Underwriter reasonably requested, and the Company hereby consents to the use of such copies for purposes permitted by the Securities Act. The Company will furnish to each Underwriter, without
        charge, during the period when a prospectus relating to the Public Securities is (or, but for the exception afforded by Rule 172, would be) required to be delivered under the Securities Act, such number of copies of the Prospectus (as amended or
        supplemented) as such Underwriter may reasonably request. The Prospectus and any amendments or supplements thereto furnished to the Underwriters will be identical to the electronically transmitted copies thereof filed with the Commission pursuant
        to EDGAR, except to the extent permitted by Regulation S-T.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">3.5&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u></u><u>Effectiveness and Events Requiring Notice to the Representative</u>.&#160; The Company shall use its best efforts&#160; to cause the Registration Statement to
        remain effective with a current prospectus forat least nine (9) months after the Applicable Time and, and shall notify the Representative immediately and confirm the notice in writing: (i)&#160;of the effectiveness of the Registration Statement and any
        amendment thereto; (ii)&#160;of the issuance by the Commission of any stop order or of the initiation, or the threatening, of any proceeding for that purpose; (iii)&#160;of the issuance by any state securities commission of any proceedings for the suspension
        of the qualification of the Public Securities for offering or sale in any jurisdiction or of the initiation, or the threatening, of any proceeding for that purpose; (iv)&#160;of the mailing and delivery to the Commission for filing of any amendment or
        supplement to the Registration Statement or Prospectus; (iv)&#160;of the receipt of any comments or request for any additional information from the Commission; and (v)&#160;of the happening of any event during the period described in this Section 3.5 that,
        in the judgment of the Company, makes any statement of a material fact made in the Registration Statement, the Disclosure Package or the Prospectus untrue or that requires the making of any changes in (a) the Registration Statement in order to make
        the statements therein not misleading, or (b) in the Disclosure Package or the Prospectus in order to make the statements therein, in light of the circumstances under which they were made, not misleading. If the Commission or any state securities
        commission shall enter a stop order or suspend such qualification at any time, the Company shall make every reasonable effort to obtain promptly the lifting of such order.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 21 -</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">3.6&#160;&#160;&#160;&#160; &#160; &#160; &#160;&#160; [Reserved].</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">3.7&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160; <u>Listing</u>.&#160; The Company shall use its commercial reasonable efforts to maintain the listing of the shares of Ordinary Shares (including the Public
        Securities) on the Exchange for at least three (3) years from the date of this Agreement.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">3.8&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160;&#160; [Reserved].</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">3.9&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160;&#160; <u>Reports to the Representative</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">3.9.1.&#160;&#160;&#160;&#160;&#160;&#160; <u>Periodic Reports, etc</u>.&#160; For a period of three (3) years after the date of this Agreement, the Company shall&#160; furnish or make available to the Representative
        copies of such financial statements and other periodic and special reports as the Company from time to time furnishes generally to holders of any class of its securities and also promptly furnish to the Representative: (i) a copy of each periodic
        report the Company shall be required to file with the Commission under the Exchange Act and the Exchange Act Regulations; (ii) a copy of every press release and every news item and article with respect to the Company or its affairs which was
        released by the Company; (iii) a copy of each Form 8-K prepared and filed by the Company; (iv) five copies of each registration statement filed by the Company under the Securities Act; (v) a copy of each report or other communication furnished to
        stockholders; and (vi) such additional documents and information with respect to the Company and the affairs of any future subsidiaries of the Company as the Representative may from time to time reasonably request; provided, however,&#160; the
        Representative shall sign, if requested by the Company, a Regulation FD compliant confidentiality agreement which is reasonably acceptable to the Representative and Representative Counsel in connection with the Representative&#8217;s receipt of such
        information. Documents filed with the Commission pursuant to its EDGAR system shall be deemed to have been delivered to the Representative pursuant to this Section 3.9.1.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">3.9.2.&#160;&#160;&#160;&#160;&#160; <u>Transfer Agent; Transfer Sheets</u>. For a period of three (3) years after the date of this Agreement, the Company shall retain a transfer agent, and registrar
        acceptable to the Representative (the&#160;&#8220;Transfer Agent&#8221;). EQ (formerly American Stock Transfer &amp; Trust Company, LLC (AST)) is acceptable to the Representative to act as Transfer Agent for the shares of Ordinary Shares.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">3.10&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Payment of Expenses</u>.&#160; The Company hereby agrees to pay on each of the Closing Date and the Option Closing Date, if any, to the extent not paid at the Closing
        Date, all expenses incident to the performance of the obligations of the Company under this Agreement: up to an aggregate amount of $75,000. The Representative may deduct from the net proceeds of the Offering payable to the Company on the Closing
        Date, or the Option Closing Date, if any, the expenses set forth herein (less any amounts previously advanced against such actual reimbursable expense) to be paid by the Company to the Underwriters; provided however, that in the event that the
        Offering is terminated, the Company agrees to reimburse the Underwriters pursuant to Section 8.3(c).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">3.11&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Application of Net Proceeds</u>.&#160; The Company shall apply the net proceeds from the Offering received by it in a manner consistent with the application thereof
        described under the caption &#8220;Use of Proceeds&#8221; in the Registration Statement, the Disclosure Package and the Prospectus.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 22 -</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">3.12&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Stabilization</u>.&#160; Neither the Company nor, to its knowledge, any of its employees, directors or stockholders (without the consent of the Representative) has
        taken or shall take directly or indirectly, any action designed to or that has constituted or that might reasonably be expected to cause or result in, under Regulation M of the Exchange Act, or otherwise, stabilization or manipulation of the price
        of any security of the Company to facilitate the sale or resale of the Public Securities.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">3.13&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Internal Controls</u>.&#160; The Company shall maintain a system of internal accounting controls sufficient to provide reasonable assurances that: (i)&#160;transactions
        are executed in accordance with management&#8217;s general or specific authorization; (ii)&#160;transactions are recorded as necessary in order to permit preparation of financial statements in accordance with GAAP and to maintain accountability for assets;
        (iii)&#160;access to assets is permitted only in accordance with management&#8217;s general or specific authorization; and (iv)&#160;the recorded accountability for assets is compared with existing assets at reasonable intervals and appropriate action is taken
        with respect to any differences.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">3.14&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Accountants</u>.&#160; As of the date of this Agreement, the Company shall continue to retain a nationally recognized independent registered public accounting firm
        for a period of at least three (3) years after the date of this Agreement.&#160; The Representative acknowledges that the Auditor is acceptable to the Representative.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">3.15&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>FINRA</u>.&#160; The Company shall advise the Representative (who shall make an appropriate filing with FINRA) if it is or becomes aware that (i) any officer or
        director of the Company, (ii) any beneficial owner of 5% or more of any class of the Company&#8217;s securities or (iii) any beneficial owner of the Company&#8217;s unregistered equity securities which were acquired during the 180 days immediately preceding
        the filing of the Registration Statement is or becomes an affiliate or associated person of a FINRA member participating in the Offering (as determined in accordance with the rules and regulations of FINRA).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">3.16&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>No Fiduciary Duties</u>.&#160; The Company acknowledges and agrees that the Underwriters&#8217; responsibility to the Company is solely contractual in nature and that none
        of the Underwriters or their affiliates or any selling agent shall be deemed to be acting in a fiduciary capacity, or otherwise owes any fiduciary duty to the Company or any of its affiliates in connection with the Offering and the other
        transactions contemplated by this Agreement.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">3.17&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Company Lock-Up Agreements</u>.<font style="font-style: italic;">&#160; </font>The Company, on behalf of itself and any successor entity, agrees that, without the
        prior written consent of the Representative, it will not for a period of sixty (60) days after the date of this Agreement (the &#8220;<font style="font-weight: bold;">Lock-Up Period</font>&#8221;), (i) offer, pledge, sell, contract to sell, sell any option or
        contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of capital stock of the Company or any securities
        convertible into or exercisable or exchangeable for shares of capital stock of the Company; (ii) file or cause to be filed any registration statement with the Commission relating to the offering of any shares of capital stock of the Company or any
        securities convertible into or exercisable or exchangeable for shares of capital stock of the Company; or (iii) complete any offering of debt securities of the Company, other than entering into a line of credit with a traditional bank or (iv) enter
        into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of capital stock of the Company, whether any such transaction described in clause (i), (ii), (iii) or (iv) above is to
        be settled by delivery of shares of capital stock of the Company or such other securities, in cash or otherwise.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 23 -</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The restrictions contained in this Section 3.17 shall not apply to (i) the shares of Ordinary Shares to be sold hereunder, (ii) the issuance by the Company of shares of Ordinary
        Shares upon the exercise of a stock option or warrant or the conversion of a security outstanding on the date hereof, which is disclosed in the Registration Statement, Disclosure Package and Prospectus or under ESOP, provided that such options,
        warrants, and securities have not been amended since the date of this Agreement to increase the number of such securities or to decrease the exercise price, exchange price or conversion price of such securities or to extend the term of such
        securities, (iii) the issuance by the Company of stock options, shares of capital stock of the Company or other awards under any equity compensation plan of the Company, provided that in each of (ii) and (iii) above, the Shares shall be restricted
        from sale during the entire Lock-Up Period.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">3.18&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Release of D&amp;O Lock-up Period</u>.&#160; If the Representative, in its sole discretion, agrees to release or waive the restrictions set forth in the Lock-Up
        Agreements described in Section 2.25 hereof for an officer or director of the Company and provide the Company with notice of the impending release or waiver at least three (3) Business Days before the effective date of the release or waiver, the
        Company agrees to announce the impending release or waiver by a press release substantially in the form of <u>Exhibit&#160;B</u> hereto through a major news service at least two (2) Business Days before the effective date of the release or waiver.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">3.19&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Blue Sky Qualifications</u>.&#160; The Company shall use its best efforts, in cooperation with the Underwriters, if necessary, to qualify the Public Securities for
        offering and sale under the applicable securities laws of such states and other jurisdictions (domestic or foreign) as the Representative may designate and to maintain such qualifications in effect so long as required to complete the distribution
        of the Public Securities; provided, however, that the Company shall not be obligated to file any general consent to service of process or to qualify as a foreign corporation or as a dealer in securities in any jurisdiction in which it is not so
        qualified or to subject itself to taxation in respect of doing business in any jurisdiction in which it is not otherwise so subject.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">3.20&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Reporting Requirements</u>.&#160; The Company, during the period when a prospectus relating to the Public Securities is (or, but for the exception afforded by Rule
        172, would be) required to be delivered under the Securities Act, will file all documents required to be filed with the Commission pursuant to the Exchange Act within the time periods required by the Exchange Act and Exchange Act Regulations.
        Additionally, the Company shall report the use of proceeds from the issuance of the Public Securities as may be required under Rule 463 under the Securities Act Regulations.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">3.21&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Press Release</u>.&#160; Prior to the Closing Date and any Option Closing Date, the Company shall not issue any press release or other communication directly or
        indirectly or hold any press conference with respect to the Company, its condition, financial or otherwise, or earnings, business affairs or business prospects (except for routine oral marketing communications in the ordinary course of business and
        consistent with the past practices of the Company and of which the Representative is notified), without the prior written consent of the Representative, which consent shall not be unreasonably withheld, unless in the judgment of the Company and its
        counsel, and after notification to the representative, such press release or communication is required by law.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">3.22&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Sarbanes Oxley</u>.&#160; The Disclosure Package and Prospectus, the Company shall at all times comply with all applicable provisions of the Sarbanes Oxley Act in
        effect from time to time.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 24 -</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; line-height: 1.25;">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Conditions of Underwriters&#8217; Obligations</u>.&#160; The obligations of the Underwriters to purchase and pay for the Public Securities, as provided herein, shall be subject to (i) the
        continuing accuracy of the representations and warranties of the Company as of the date hereof and as of each of the Closing Date and the Option Closing Date, if any; (ii) the accuracy of the statements of officers of the Company made pursuant to
        the provisions hereof; (iii) the performance by the Company of its obligations hereunder; and (iv) the following conditions:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">4.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Regulatory Matters</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">4.1.1.&#160;&#160;&#160;&#160;&#160; <u>Commission Actions; Required Filings</u>.&#160; At each of the Closing Date and any Option Closing Date, no stop order suspending the effectiveness of the Registration
        Statement or any post-effective amendment thereto has been issued under the Securities Act, no order preventing or suspending the use of the Prospectus has been issued and no proceedings for any of those purposes have been instituted or are pending
        or, to the Company&#8217;s knowledge, contemplated by the Commission. The Company has complied with each request (if any) from the Commission for additional information. A Prospectus containing the Rule 430B Information shall have been filed with the
        Commission in the manner and within the time frame required by Rule 424(b) under the Securities Act Regulations (without reliance on Rule 424(b)(8)) or a post-effective amendment providing such information shall have been filed with, and declared
        effective by, the Commission in accordance with the requirements of Rule 430B under the Securities Act regulations.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">4.1.2.&#160;&#160;&#160;&#160;&#160;&#160; <u>FINRA Clearance</u>.&#160; On or before the date of this Agreement, the Representative shall have received clearance from FINRA as to the amount of compensation
        allowable or payable to the Underwriters as described in the Registration Statement.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">4.1.3.&#160;&#160;&#160;&#160;&#160; <u>Exchange Clearance</u>.&#160; On the Closing Date, the Company&#8217;s shares of Ordinary Shares, including the Firm Shares, shall have been approved for listing on the
        Exchange, subject only to official notice of issuance. On the first Option Closing Date (if any), the Company&#8217;s shares of Ordinary Shares, including the Option Shares, shall have been approved for listing on the Exchange, subject only to official
        notice of issuance.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">4.2&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Company Counsel Matters</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">4.2.1.&#160;&#160;&#160;&#160;&#160; <u>Closing Date Opinion of Counsel</u>.&#160; On the Closing Date, the Representative shall have received the favorable opinion of Carter Ledyard &amp; Milburn LLP,
        counsel to the Company, and a written statement providing certain &#8220;10b-5&#8221; negative assurances, dated the Closing Date and addressed to the Representative, in a form reasonably acceptable to the Representative.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">4.2.2.&#160;&#160;&#160;&#160;&#160;&#160; <u></u><u>Closing Date Opinion of Israeli Counsel</u>.&#160; On the Closing Date, the Representative shall have received the favorable opinion of Amit, Pollak, Matalon
        &amp; Co., Israeli counsel to the Company, dated the Closing Date and addressed to the Representative, in a form reasonably acceptable to the Representative.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">4.2.3.&#160;&#160;&#160;&#160;&#160;&#160; <u>Option Closing Date Opinions of Counsel</u>. On the Option Closing Date, if any, the Representative shall have received the favorable opinions of each counsel
        listed in Section 4.2.1 and 4.2.2., dated the Option Closing Date, addressed to the Representative and in form and substance reasonably satisfactory to the Representative, confirming as of the Option Closing Date, the statements made by such
        counsels in their respective opinions delivered on the Closing Date.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">4.2.4.&#160;&#160;&#160;&#160;&#160; <u>Reliance</u>. In rendering such opinions, such counsel may rely: (i)&#160;as to matters involving the application of laws other than the laws of the United States and
        jurisdictions in which they are admitted, to the extent such counsel deems proper and to the extent specified in such opinion, if at all, upon an opinion or opinions (in form and substance reasonably satisfactory to the Representative) of other
        counsel reasonably acceptable to the Representative, familiar with the applicable laws; and (ii)&#160;as to matters of fact, to the extent they deem proper, on certificates or other written statements of officers of the Company and officers of
        departments of various jurisdictions having custody of documents respecting the corporate existence or good standing of the Company, provided that copies of any such statements or certificates shall be delivered to Representative Counsel if
        requested.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 25 -</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">4.3&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160; <u>Comfort Letters</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">4.3.1.&#160;&#160;&#160;&#160;&#160; <u>Cold Comfort Letter</u>.&#160; At the time this Agreement is executed you shall have received a cold comfort letter containing statements and information of the type
        customarily included in accountants&#8217; comfort letters with respect to the financial statements and certain financial information contained or incorporated by reference or deemed incorporated by reference in the Registration Statement, the Disclosure
        Package and the Prospectus, addressed to the Representative and in form and substance satisfactory in all respects to you and to the Auditor, dated as of the date of this Agreement.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">4.3.2.&#160;&#160;&#160;&#160;&#160;&#160; <u></u><u>Bring-down Comfort Letter</u>.&#160; At each of the Closing Date and the Option Closing Date, if any, the Representative shall have received from the Auditor a
        letter, dated as of the Closing Date or the Option Closing Date, as applicable, to the effect that the Auditor reaffirms the statements made in their letter furnished pursuant to Section 4.3.1, except that the specified date referred to shall be a
        date not more than three (3) business days prior to the Closing Date or the Option Closing Date, as applicable.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">4.4&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160;&#160; <u>Officers&#8217; Certificates</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">4.4.1.&#160;&#160;&#160;&#160;&#160; <u>Officers&#8217; Certificate</u>.&#160; The Company shall have furnished to the Representative a certificate, dated the Closing Date and any Option Closing Date (if such date
        is other than the Closing Date), of its Chief Executive Officer and its Chief Financial Officer stating that (i) such officers have carefully examined the Registration Statement, the Disclosure Package, any Issuer Free Writing Prospectus and the
        Prospectus and, in their opinion, the Registration Statement and each amendment thereto, as of the Applicable Time and as of the Closing Date (or any Option Closing Date if such date is other than the Closing Date) did not include any untrue
        statement of a material fact and did not omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading, and the Disclosure Package, as of the Applicable Time and as of the Closing Date (or
        any Option Closing Date if such date is other than the Closing Date), any Issuer Free Writing Prospectus as of its date and as of the Closing Date (or any Option Closing Date if such date is other than the Closing Date), and the Prospectus and each
        amendment or supplement thereto, as of the respective date thereof and as of the Closing Date, did not include any untrue statement of a material fact and did not omit to state a material fact necessary in order to make the statements therein, in
        the light of the circumstances in which they were made, not misleading, (ii) since the effective date of the Registration Statement, no event has occurred which should have been set forth in a supplement or amendment to the Registration Statement,
        the Disclosure Package or the Prospectus, (iii) to the best of their knowledge after reasonable investigation,&#160; as of the Closing Date (or any Option Closing Date if such date is other than the Closing Date), the representations and warranties of
        the Company in this Agreement are true and correct and the Company has complied with all agreements and satisfied all conditions on its part to be performed or satisfied hereunder at or prior to the Closing Date (or any Option Closing Date if such
        date is other than the Closing Date), and (iv) there has not been, subsequent to the date of the most recent audited financial statements included or incorporated by reference in the Disclosure Package, any material adverse change in the financial
        position or results of operations of the Company, or any change or development that, singularly or in the aggregate, would involve a material adverse change or a prospective material adverse change, in or affecting the condition (financial or
        otherwise), results of operations, business, assets or prospects of the Company, except as set forth in the Prospectus.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 26 -</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">4.4.2.&#160;&#160;&#160;&#160;&#160; <u>CEO&#8217;s Certificate</u>.&#160; At each of the Closing Date and the Option Closing Date, if any, the Representative shall have received a certificate of the Company
        signed by the CEO of the Company, dated the Closing Date or the Option Date, as the case may be, respectively, certifying: (i)&#160;that each of the Charter and Bylaws is true and complete, has not been modified and is in full force and effect;
        (ii)&#160;that the resolutions of the Company&#8217;s Board of Directors relating to the Offering are in full force and effect and have not been modified; (iii) as to the accuracy and completeness of all correspondence between the Company or its counsel and
        the Commission; and (iv)&#160;as to the incumbency of the officers of the Company. The documents referred to in such certificate shall be attached to such certificate.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">4.4.3.&#160;&#160;&#160;&#160; <u>Chief Financial Officer&#8217;s Certificate</u>. At each of the Closing Date and the Option Closing Date, if any, the Representative shall have received a certificate of
        the Chief Financial Officer of the Company, dated the Closing Date or the Option Date, as the case may be, respectively, with respect to the accuracy of certain information contained in the Registration Statement, the Disclosure Package and the
        Prospectus, in a form reasonably acceptable to the Representative.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">4.5&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160; <u>No Material Changes</u>.&#160; Prior to and on each of the Closing Date and each Option Closing Date, if any: (i)&#160;there shall have been no Material Adverse Change or
        development involving a prospective Material Adverse Change from the latest dates as of which such condition is set forth in the Registration Statement and no change in the capital stock or debt of the Company, the Disclosure Package and the
        Prospectus; (ii) no action, suit or proceeding, at law or in equity, shall have been pending or threatened against the Company or any Insider before or by any court or federal or state commission, board or other administrative agency wherein an
        unfavorable decision, ruling or finding may materially adversely affect the business, operations, properties, assets, prospects or financial condition or income of the Company, except as set forth in the Registration Statement, the Disclosure
        Package and the Prospectus; (iii)&#160;no stop order shall have been issued under the Securities Act and no proceedings therefor shall have been initiated or threatened by the Commission; (iv) no action shall have been taken and no law, statute, rule,
        regulation or order shall have been enacted, adopted or issued by any Governmental Entity which would prevent the issuance or sale of the Public Securities or materially and adversely affect or potentially materially and adversely affect the
        business or operations of the Company; (v) no injunction, restraining order or order of any other nature by any federal or state court of competent jurisdiction shall have been issued which would prevent the issuance or sale of the Public
        Securities or materially and adversely affect or potentially materially and adversely affect the business or operations of the Company; and (vi)&#160;the Registration Statement, the Disclosure Package and the Prospectus and any amendments or supplements
        thereto shall contain all material statements which are required to be stated therein in accordance with the Securities Act and the Securities Act Regulations and shall conform in all material respects to the requirements of the Securities Act and
        the Securities Act Regulations, and neither the Registration Statement, the Disclosure Package nor the Prospectus nor any amendment or supplement thereto shall contain any untrue statement of a material fact or omit to state any material fact
        required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">4.6&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Corporate Proceedings</u>. All corporate proceedings and other legal matters incident to the authorization, form and validity of each of this Agreement, the
        Public Securities, the Registration Statement, the Disclosure Package and the Prospectus and all other legal matters relating to this Agreement and the transactions contemplated hereby and thereby shall be reasonably satisfactory in all material
        respects to counsel for the Underwriters, and the Company shall have furnished to such counsel all documents and information that they may reasonably request to enable them to pass upon such matters.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 27 -</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">4.7&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <u>Delivery of Agreements</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">4.7.1.&#160;&#160;&#160;&#160;&#160;&#160; <u>Lock-Up Agreements</u>.&#160; On or before the date of this Agreement, the Company shall have delivered to the Representative executed copies of the Lock-Up
        Agreements from each of the persons listed in <u>Schedule 3</u> hereto.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">4.8&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Additional Documents</u>.&#160; At the Closing Date and at each Option Closing Date (if any) Representative Counsel shall have been furnished with such documents and
        opinions as they may require for the purpose of enabling Representative Counsel to deliver an opinion to the Underwriters, or in order to evidence the accuracy of any of the representations or warranties, or the fulfillment of any of the
        conditions, herein contained; and all proceedings taken by the Company in connection with the issuance and sale of the Public Securities and the as herein contemplated shall be satisfactory in form and substance to the Representative and
        Representative Counsel.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">5.&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; &#160; <u>Indemnification</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">5.1&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>Indemnification of the Underwriters</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">5.1.1.&#160;&#160;&#160;&#160;&#160;&#160; <u>General</u>.&#160; Subject to the conditions set forth below, the Company agrees to indemnify and hold harmless each Underwriter, its affiliates and each of its and
        their respective directors, officers, members, employees, representatives, partners, stockholders, affiliates, counsel, and agents and each person, if any, who controls any such Underwriter within the meaning of Section 15 of the Securities Act or
        Section 20 of the Exchange Act (collectively the &#8220;<font style="font-weight: bold;">Underwriter Indemnified Parties</font>,&#8221; and each an &#8220;<font style="font-weight: bold;">Underwriter Indemnified Party</font>&#8221;), against any and all loss, liability,
        claim, damage and expense whatsoever (including but not limited to any and all legal or other expenses reasonably incurred in investigating, preparing or defending against any litigation, commenced or threatened, or any claim whatsoever, whether
        arising out of any action between any of the Underwriter Indemnified Parties and the Company or between any of the Underwriter Indemnified Parties and any third party, or otherwise) to which they or any of them may become subject under the
        Securities Act, the Exchange Act or any other statute or at common law or otherwise or under the laws of foreign countries (a &#8220;Claim&#8221;), (i) arising out of or based upon any untrue statement or alleged untrue statement of a material fact contained
        in (A) the Registration Statement, the Disclosure Package, the Prospectus, or in any Issuer Free Writing Prospectus or in any Written Testing-the-Waters Communication (as from time to time each may be amended and supplemented); (B) any materials or
        information provided to investors by, or with the approval of, the Company in connection with the marketing of the Offering, including any &#8220;road show&#8221; or investor presentations made to investors by the Company (whether in person or electronically);
        or (C) any application or other document or written communication (in this Section 5, collectively called &#8220;application&#8221;) executed by the Company or based upon written information furnished by the Company in any jurisdiction in order to qualify the
        Public Securities under the securities laws thereof or filed with the Commission, any state securities commission or agency, the Exchange or any other national securities exchange; or the omission or alleged omission therefrom of a material fact
        required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading, unless such statement or omission was made in reliance upon, and in conformity with, the
        Underwriters&#8217; Information or (ii) otherwise arising in connection with or allegedly in connection with the Offering.&#160; The Company also agrees that it will reimburse each Underwriter Indemnified Party for all fees and expenses (including but not
        limited to any and all legal or other expenses reasonably incurred in investigating, preparing or defending against any litigation, commenced or threatened, or any claim whatsoever, whether arising out of any action between any of the Underwriter
        Indemnified Parties and the Company or between any of the Underwriter Indemnified Parties and any third party, or otherwise) (collectively, the &#8220;<font style="font-weight: bold;">Expenses</font>&#8221;), and further agrees wherever and whenever possible
        to advance payment of Expenses as they are incurred by an Underwriter Indemnified Party in investigating, preparing, pursuing or defending any Claim.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 28 -</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">5.1.2.&#160;&#160;&#160;&#160;&#160;&#160; <u>Procedure</u>.<font style="font-weight: bold;">&#160; </font>If any action is brought against an Underwriter Indemnified Party in respect of which indemnity may be
        sought against the Company pursuant to Section 5.1.1, such Underwriter Indemnified Party shall promptly notify the Company in writing of the institution of such action and the Company shall assume the defense of such action, including the
        employment and fees of counsel (subject to the approval of such Underwriter Indemnified Party) and payment of actual expenses if an Underwriter Indemnified Party requests that the Company do so. Such Underwriter Indemnified Party shall have the
        right to employ its or their own counsel in any such case, but the fees and expenses of such counsel shall be at the expense of the Company, and shall be advanced by the Company. The Company shall not be liable for any settlement of any action
        effected without its consent (which shall not be unreasonably withheld). In addition, the Company shall not, without the prior written consent of the Underwriters, settle, compromise or consent to the entry of any judgment in or otherwise seek to
        terminate any pending or threatened action in respect of which advancement, reimbursement, indemnification or contribution may be sought hereunder (whether or not such Underwriter Indemnified Party is a party thereto) unless such settlement,
        compromise, consent or termination (i) includes an unconditional release of each Underwriter Indemnified Party, acceptable to such Underwriter Indemnified Party, from all liabilities, expenses and claims arising out of such action for which
        indemnification or contribution may be sought and (ii) does not include a statement as to or an admission of fault, culpability or a failure to act, by or on behalf of any Underwriter Indemnified Party.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">5.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Indemnification of the Company</u>.&#160; Each Underwriter, severally and not jointly, agrees to indemnify and hold harmless the Company, its directors, its officers
        who signed the Registration Statement and persons who control the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act against any and all loss, liability, claim, damage and expense described in the
        foregoing indemnity from the Company to the several Underwriters, as incurred, but only with respect to untrue statements or omissions made in the Registration Statement, the Disclosure Package or Prospectus or any amendment or supplement thereto
        or in any application, in reliance upon, and in strict conformity with, the Underwriters&#8217; Information. In case any action shall be brought against the Company or any other person so indemnified based on the Registration Statement, the Disclosure
        Package or Prospectus or any amendment or supplement thereto or any application, and in respect of which indemnity may be sought against any Underwriter, such Underwriter shall have the rights and duties given to the Company, and the Company and
        each other person so indemnified shall have the rights and duties given to the several Underwriters by the provisions of Section 5.1.2.&#160; The Company agrees promptly to notify the Representative of the commencement of any litigation or proceedings
        against the Company or any of its officers, directors or any person, if any, who controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, in connection with the issuance and sale of the Public
        Securities or in connection with the Registration Statement, the Disclosure Package, the Prospectus, or any Issuer Free Writing Prospectus or any Written Testing-the-Waters Communication.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">5.3&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160;&#160; <u>Contribution</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">5.3.1.&#160;&#160;&#160;&#160;&#160; <u>Contribution Rights</u>.&#160; If the indemnification provided for in this Section 5 shall for any reason be unavailable to or insufficient to hold harmless an
        indemnified party under Section 5.1 or 5.2 in respect of any loss, claim, damage or liability, or any action in respect thereof, referred to therein, then each indemnifying party shall, in lieu of indemnifying such indemnified party, contribute to
        the amount paid or payable by such indemnified party as a result of such loss, claim, damage or liability, or action in respect thereof, (i) in such proportion as shall be appropriate to reflect the relative benefits received by the Company, on the
        one hand, and the Underwriters, on the other, from the Offering of the Public Securities, or (ii) if the allocation provided by clause (i) above is not permitted by applicable law, in such proportion as is appropriate to reflect not only the
        relative benefits referred to in clause (i) above but also the relative fault of the Company, on the one hand, and the Underwriters, on the other, with respect to the statements or omissions that resulted in such loss, claim, damage or liability,
        or action in respect thereof, as well as any other relevant equitable considerations.&#160; The relative benefits received by the Company, on the one hand, and the Underwriters, on the other, with respect to such Offering shall be deemed to be in the
        same proportion as the total net proceeds from the Offering of the Public Securities purchased under this Agreement (before deducting expenses) received by the Company, as set forth in the table on the cover page of the Prospectus, on the one hand,
        and the total underwriting discounts and commissions received by the Underwriters with respect to the shares of the Ordinary Shares purchased under this Agreement, as set forth in the table on the cover page of the Prospectus, on the other hand.&#160;
        The relative fault shall be determined by reference to whether the untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information supplied by the Company or the Underwriters,
        the intent of the parties and their relative knowledge, access to information and opportunity to correct or prevent such statement or omission.&#160; The Company and the Underwriters agree that it would not be just and equitable if contributions
        pursuant to this Section 5.3.1 were to be determined by pro rata allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method of allocation that does not take into account the equitable considerations
        referred to herein.&#160; The amount paid or payable by an indemnified party as a result of the loss, claim, damage or liability, or action in respect thereof, referred to above in this Section 5.3.1 shall be deemed to include, for purposes of this
        Section 5.3.1, any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim.&#160; Notwithstanding the provisions of this Section 5.3.1 in no event shall an Underwriter
        be required to contribute any amount in excess of the amount by which the total underwriting discounts and commissions received by such Underwriter with respect to the Offering of the Public Securities exceeds the amount of any damages that such
        Underwriter has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission.&#160; No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall
        be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 29 -</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%30%- % -%-->
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">5.3.2.&#160;&#160;&#160;&#160;&#160;&#160; <u></u><u>Contribution Procedure</u>.&#160; Within fifteen (15) days after receipt by any party to this Agreement (or its representative) of notice of the commencement
        of any action, suit or proceeding, such party will, if a claim for contribution in respect thereof is to be made against another party (&#8220;contributing party&#8221;), notify the contributing party of the commencement thereof, but the failure to so notify
        the contributing party will not relieve it from any liability which it may have to any other party other than for contribution hereunder. In case any such action, suit or proceeding is brought against any party, and such party notifies a
        contributing party or its representative of the commencement thereof within the aforesaid 15 days, the contributing party will be entitled to participate therein with the notifying party and any other contributing party similarly notified. Any such
        contributing party shall not be liable to any party seeking contribution on account of any settlement of any claim, action or proceeding affected by such party seeking contribution on account of any settlement of any claim, action or proceeding
        affected by such party seeking contribution without the written consent of such contributing party. The contribution provisions contained in this Section 5.3.2 are intended to supersede, to the extent permitted by law, any right to contribution
        under the Securities Act, the Exchange Act or otherwise available.&#160; Each Underwriter&#8217;s obligations to contribute pursuant to this Section 5.3 are several and not joint.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">6.&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <u>Default by an Underwriter</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">6.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Default Not Exceeding 10% of Firm Shares or Option Shares</u>. If any Underwriter or Underwriters shall default in its or their obligations to purchase the Firm
        Shares or the Option Shares, if the Over-allotment Option is exercised hereunder, and if the number of the Firm Shares or Option Shares with respect to which such default relates does not exceed in the aggregate 10% of the number of Firm Shares or
        Option Shares that all Underwriters have agreed to purchase hereunder, then such Firm Shares or Option Shares to which the default relates shall be purchased by the non-defaulting Underwriters in proportion to their respective commitments
        hereunder.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">- 30 -</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">6.2&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160; <u>Default Exceeding 10% of Firm Shares or Option Shares</u>. In the event that the default addressed in Section 6.1 relates to more than 10% of the Firm Shares or
        Option Shares, you may in your discretion arrange for yourself or for another party or parties to purchase such Firm Shares or Option Shares to which such default relates on the terms contained herein. If, within one (1) Business Day after such
        default relating to more than 10% of the Firm Shares or Option Shares, you do not arrange for the purchase of such Firm Shares or Option Shares, then the Company shall be entitled to a further period of one (1) Business Day within which to procure
        another party or parties satisfactory to you to purchase said Firm Shares or Option Shares on such terms. In the event that neither you nor the Company arrange for the purchase of the Firm Shares or Option Shares to which a default relates as
        provided in this Section 6, this Agreement will automatically be terminated by you or the Company without liability on the part of the Company (except as provided in Sections 3.10 and 5 hereof) or the several Underwriters (except as provided in
        Section 5 hereof); provided, however, that if such default occurs with respect to the Option Shares, this Agreement will not terminate as to the Firm Shares; and provided, further, that nothing herein shall relieve a defaulting Underwriter of its
        liability, if any, to the other Underwriters and to the Company for damages occasioned by its default hereunder.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">6.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Postponement of Closing Date</u>.&#160; In the event that the Firm Shares or Option Shares to which the default relates are to be purchased by the non-defaulting
        Underwriters, or are to be purchased by another party or parties as aforesaid, you or the Company shall have the right to postpone the Closing Date or Option Closing Date for a reasonable period, but not in any event exceeding five (5) Business
        Days, in order to effect whatever changes may thereby be made necessary in the Registration Statement, the Disclosure Package or the Prospectus or in any other documents and arrangements, and the Company agrees to file promptly any amendment to the
        Registration Statement, the Disclosure Package or the Prospectus that in the opinion of counsel for the Underwriter may thereby be made necessary.&#160; The term &#8220;Underwriter&#8221; as used in this Agreement shall include any party substituted under this
        Section 6 with like effect as if it had originally been a party to this Agreement with respect to such shares of Ordinary Shares.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">7.&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; &#160; <u>Additional Covenants</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">7.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Board Composition and Board Designations</u>.&#160; The Company shall ensure that: (i)&#160;the qualifications of the persons serving as members of the Board of Directors
        and the overall composition of the Board comply with the Sarbanes-Oxley Act, with the Exchange Act and with the listing rules of the Exchange or any other national securities exchange, as the case may be, in the event the Company seeks to have its
        Public Securities listed on another exchange or quoted on an automated quotation system, and (ii)&#160;if applicable, at least one member of the Audit Committee of the Board of Directors qualifies as an &#8220;audit committee financial expert,&#8221; as such term
        is defined under Regulation S-K and the listing rules of the Exchange.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">7.2&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <u>Prohibition on Press Releases and Public Announcements</u>.&#160; The Company shall not issue press releases or engage in any other publicity, without the
        Representative&#8217;s prior written consent, for a period ending at 5:00 p.m., Eastern time, on the first (1<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup>) Business Day following the forty-fifth (45<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup>) day after the Closing Date, other than normal and customary releases
        issued in the ordinary course of the Company&#8217;s business.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;" class="BRPFPageNumber">- 31 -</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">8.&#160;&#160;&#160;&#160;&#160; &#160; &#160; &#160;&#160; <u>Effective Date of this Agreement and Termination Thereof</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">8.1&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Effective Date</u>.&#160; This Agreement shall become effective when both the Company and the Representative have executed the same and delivered counterparts of
        such signatures to the other party.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">8.2&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160; <u>Termination</u>.&#160; The Representative shall have the right to terminate this Agreement at any time prior to any Closing Date, (i)&#160;if any domestic or
        international event or act or occurrence has materially disrupted, or in your opinion will in the immediate future materially disrupt, general securities markets in the United States; or (ii)&#160;if trading on the New York Stock Exchange or the Nasdaq
        Stock Market LLC shall have been suspended or materially limited, or minimum or maximum prices for trading shall have been fixed, or maximum ranges for prices for securities shall have been required by FINRA or by order of the Commission or any
        other government authority having jurisdiction; or (iii)&#160;if the United States shall have become involved in a new war or an increase in major hostilities; or (iv)&#160;if a banking moratorium has been declared by a New York State or federal authority;
        or (v)&#160;if a moratorium on foreign exchange trading has been declared which materially adversely impacts the United States or Israeli securities markets; or (vi)&#160;if the Company shall have sustained a material loss by fire, flood, accident,
        hurricane, earthquake, theft, sabotage or other calamity or malicious act which, whether or not such loss shall have been insured, will, in your opinion, make it inadvisable to proceed with the delivery of the Firm Shares or Option Shares; or
        (vii)&#160;if the Company is in material breach of any of its representations, warranties or covenants hereunder; or (viii)&#160;if the Representative shall have become aware after the date hereof of such a Material Adverse Change, or such Material Adverse
        Change in general market conditions as in the Representative&#8217;s judgment would make it impracticable to proceed with the offering, sale and/or delivery of the Public Securities or to enforce contracts made by the Underwriters for the sale of the
        Public Securities.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">8.3&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <u>Expenses</u>.&#160; Notwithstanding anything to the contrary in this Agreement, except in the case of a default by the Underwriters, pursuant to Section 6.2 above,
        in the event that this Agreement shall not be carried out for any reason whatsoever, within the time specified herein or any extensions thereof pursuant to the terms herein, the Company shall be obligated to pay to the Underwriters their actual and
        accountable out-of-pocket expenses related to the transactions contemplated herein then due and payable (including the fees and disbursements of Representative Counsel) up to $75,000, inclusive of the $25,000 advance for out-of-pocket accountable
        expenses previously paid by the Company to the Representative and upon demand the Company shall pay the full amount thereof to the Representative on behalf of the Underwriters; provided, however, that such expense cap in no way limits or impairs
        the indemnification and contribution provisions of this Agreement.&#160; Notwithstanding the foregoing, any advance received by the Representative will be reimbursed to the Company to the extent not actually incurred in compliance with FINRA Rule
        5110(g)(4)(A).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">8.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Indemnification</u>.&#160; Notwithstanding any contrary provision contained in this Agreement, any election hereunder or any termination of this Agreement, and whether
        or not this Agreement is otherwise carried out, the provisions of Section 5 shall remain in full force and effect and shall not be in any way affected by, such election or termination or failure to carry out the terms of this Agreement or any part
        hereof.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">8.5&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Representations, Warranties, Agreements to Survive</u>.&#160; All representations, warranties and agreements contained in this Agreement or in certificates of officers
        of the Company submitted pursuant hereto, shall remain operative and in full force and effect regardless of (i)&#160;any investigation made by or on behalf of any Underwriter or its Affiliates or selling agents, any person controlling any Underwriter,
        its officers or directors or any person controlling the Company or (ii)&#160;delivery of and payment for the Public Securities.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;" class="BRPFPageNumber">- 32 -</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; line-height: 1.25;">9.&#160;&#160;&#160; &#160; &#160; &#160;&#160;&#160;&#160; <u>Miscellaneous</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">9.1&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Notices</u>.&#160; All communications hereunder, except as herein otherwise specifically provided, shall be in writing and shall be mailed (registered or certified
        mail, return receipt requested), personally delivered or sent by electronic mail transmission and confirmed and shall be deemed given when so delivered and confirmed or if mailed, two (2) days after such mailing.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="margin-left: 36pt; line-height: 1.25;">If to the Representative:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="margin-left: 36pt; line-height: 1.25;">ThinkEquity LLC</div>
      <div style="margin-left: 36pt; line-height: 1.25;">17 State Street, 41<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup> Floor</div>
      <div style="margin-left: 36pt; line-height: 1.25;">New York, New York 10004<br>
        Attn: Head of Investment Banking</div>
      <div style="margin-left: 36pt; line-height: 1.25;">Email: Notices@think-equity.com</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="margin-left: 36pt; line-height: 1.25;">with a copy (which shall not constitute notice) to:</div>
      <div style="margin-left: 35.1pt; line-height: 1.25;"><br>
        Sullivan &amp; Worcester LLP</div>
      <div style="margin-left: 35.1pt; line-height: 1.25;">1633 Broadway</div>
      <div style="margin-left: 35.1pt; line-height: 1.25;">New York, New York 10019</div>
      <div style="margin-left: 35.1pt; line-height: 1.25;">Attention: Ron Ben-Bassat, Esq.</div>
      <div style="margin-left: 35.1pt; line-height: 1.25;">Fax No.: (212) 660-3001</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="margin-left: 36pt; line-height: 1.25;">If to the Company:</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="margin-left: 36pt; line-height: 1.25;">20 Ben Zion Gelis Street</div>
      <div style="margin-left: 36pt; line-height: 1.25;">Sgoola Industrial Zone</div>
      <div style="margin-left: 36pt; line-height: 1.25;">Petach Tikva 4927920, Israel</div>
      <div style="margin-left: 36pt; line-height: 1.25;">Attention: Ron Freund</div>
      <div style="margin-left: 36pt; line-height: 1.25;">Email: Ronf@nisteceltek.com</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="margin-left: 36pt; line-height: 1.25;">with a copy (which shall not constitute notice) to:</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="margin-left: 36pt; line-height: 1.25;">Carter Ledyard &amp; Milburn LLP</div>
      <div style="margin-left: 36pt; line-height: 1.25;">28 Liberty Street</div>
      <div style="margin-left: 36pt; line-height: 1.25;">41st Fl.</div>
      <div style="margin-left: 36pt; line-height: 1.25;">New York, New York 10005</div>
      <div style="margin-left: 36pt; line-height: 1.25;">Attention:</div>
      <div style="margin-left: 36pt; line-height: 1.25;">Email:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">9.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Research Analyst Independence. The Company acknowledges that each Underwriter&#8217;s research analysts and research departments are required to be independent from its
        investment banking division and are subject to certain regulations and internal policies, and that such Underwriter&#8217;s research analysts may hold views and make statements or investment recommendations and/or publish research reports with respect to
        the Company and/or the Offering that differ from the views of their investment banking division. The Company acknowledges that each Underwriter is a full service securities firm and as such from time to time, subject to applicable securities laws,
        rules and regulations, may effect transactions for its own account or the account of its customers and hold long or short positions in debt or equity securities of the Company; provided, however, that nothing in this Section 9.2 shall relieve the
        Underwriter of any responsibility or liability it may otherwise bear in connection with activities in violation of applicable securities laws, rules or regulations.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;" class="BRPFPageNumber">- 33 -</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%34%- % -%-->
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">9.3&#160;&#160;&#160;&#160; &#160;&#160; &#160;&#160;&#160; <u>Headings</u>.&#160; The headings contained herein are for the sole purpose of convenience of reference, and shall not in any way limit or affect the meaning or
        interpretation of any of the terms or provisions of this Agreement.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">9.4&#160;&#160;&#160;&#160; &#160; &#160; &#160;&#160; <u>Amendment</u>.&#160; This Agreement may only be amended by a written instrument executed by each of the parties hereto.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">9.5&#160;&#160;&#160;&#160; &#160; &#160; &#160;&#160; <u>Entire Agreement</u>.&#160; This Agreement (together with the other agreements and documents being delivered pursuant to or in connection with this Agreement)
        constitutes the entire agreement of the parties hereto with respect to the subject matter hereof and thereof, and supersedes all prior agreements and understandings of the parties, oral and written, with respect to the subject matter hereof.&#160;
        Notwithstanding anything to the contrary set forth herein, it is understood and agreed by the parties hereto that all other terms and conditions of that certain engagement letter between the Company and ThinkEquity LLC, dated December 14, 2023,
        shall remain in full force and effect.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">9.6&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Binding Effect</u>.&#160; This Agreement shall inure solely to the benefit of and shall be binding upon the Representative, the Underwriters, the Company and the
        controlling persons, directors and officers referred to in Section 5 hereof, and their respective successors, legal representatives, heirs and assigns, and no other person shall have or be construed to have any legal or equitable right, remedy or
        claim under or in respect of or by virtue of this Agreement or any provisions herein contained. The term &#8220;successors and assigns&#8221; shall not include a purchaser, in its capacity as such, of securities from any of the Underwriters.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">9.7&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Governing Law; Consent to Jurisdiction; Trial by Jury</u>.&#160; This Agreement shall be governed by and construed and enforced in accordance with the laws of the
        State of New York, without giving effect to conflict of laws principles thereof. The Company hereby agrees that any action, proceeding or claim against it arising out of, or relating in any way to this Agreement shall be brought and enforced in the
        New York Supreme Court, County of New York, or in the United States District Court for the Southern District of New York, and irrevocably submits to such jurisdiction, which jurisdiction shall be exclusive. The Company hereby waives any objection
        to such exclusive jurisdiction and that such courts represent an inconvenient forum. Any such process or summons to be served upon the Company may be served by transmitting a copy thereof by registered or certified mail, return receipt requested,
        postage prepaid, addressed to it at the address set forth in Section 9.1 hereof. Such mailing shall be deemed personal service and shall be legal and binding upon the Company in any action, proceeding or claim. The Company agrees that the
        prevailing party(ies) in any such action shall be entitled to recover from the other party(ies) all of its reasonable attorneys&#8217; fees and expenses relating to such action or proceeding and/or incurred in connection with the preparation therefor.
        The Company (on its behalf and, to the extent permitted by applicable law, on behalf of its stockholders and affiliates) and each of the Underwriters hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to
        trial by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated hereby.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">9.8&#160;&#160; &#160; &#160;&#160;&#160;&#160;&#160; <u>Execution in Counterparts</u>.&#160; This Agreement may be executed in one or more counterparts, and by the different parties hereto in separate counterparts, each
        of which shall be deemed to be an original, but all of which taken together shall constitute one and the same agreement, and shall become effective when one or more counterparts has been signed by each of the parties hereto and delivered to each of
        the other parties hereto. Delivery of a signed counterpart of this Agreement by facsimile or email/pdf transmission shall constitute valid and sufficient delivery thereof.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">9.9&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <u>Waiver, etc</u>.&#160; The failure of any of the parties hereto to at any time enforce any of the provisions of this Agreement shall not be deemed or construed to be
        a waiver of any such provision, nor to in any way effect the validity of this Agreement or any provision hereof or the right of any of the parties hereto to thereafter enforce each and every provision of this Agreement. No waiver of any breach,
        non-compliance or non-fulfillment of any of the provisions of this Agreement shall be effective unless set forth in a written instrument executed by the party or parties against whom or which enforcement of such waiver is sought; and no waiver of
        any such breach, non-compliance or non-fulfillment shall be construed or deemed to be a waiver of any other or subsequent breach, non-compliance or non-fulfillment.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25;">[Signature Page Follows]</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;" class="BRPFPageNumber">- 34 -</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div class="BRPFPageFooter"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If the foregoing correctly sets forth the understanding between the Underwriters and the Company, please so indicate in the space provided below for that purpose, whereupon this
        letter shall constitute a binding agreement between us.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">
        <table cellspacing="0" cellpadding="0" border="0" id="zbe975a877a144065bc64060f5666672a" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 50%; vertical-align: top;">&#160;</td>
              <td style="vertical-align: top;" colspan="2">
                <div style="line-height: 1.25;">Very truly yours,</div>
                <div style="line-height: 1.25;"> <br>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">&#160;</td>
              <td style="vertical-align: top;" colspan="2">
                <div style="line-height: 1.25;">ELTEK LTD.</div>
                <div style="line-height: 1.25;"> <br>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
              <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
                <div style="line-height: 1.25;">By:</div>
              </td>
              <td style="width: 27%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">/s/ ELTEK LTD. </td>
              <td style="width: 20%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">&#160;</td>
              <td style="width: 3%; vertical-align: top;">&#160;</td>
              <td style="width: 27%; vertical-align: top;">
                <div style="line-height: 1.25;">Name: Eli Yaffe, Ron Freund</div>
              </td>
              <td style="width: 20%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">&#160;</td>
              <td style="width: 3%; vertical-align: top;">&#160;</td>
              <td style="width: 27%; vertical-align: top;">
                <div style="line-height: 1.25;">Title: CEO, CFO</div>
              </td>
              <td style="width: 20%; vertical-align: top;">&#160;</td>
            </tr>

        </table>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="margin-right: 276.9pt; line-height: 1.25;"></div>
        <table cellspacing="0" cellpadding="0" border="0" id="z5eeca8776f0d41f6b779dbe3652b2565" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td colspan="2" rowspan="1" style="width: 3%; vertical-align: top;">
                <div style="line-height: 1.25;">Confirmed as of the date first written above mentioned, on behalf of itself and as Representative of the several Underwriters named on <u>Schedule 1</u> hereto:</div>
              </td>
              <td rowspan="1" style="width: 70%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td colspan="2" rowspan="1" style="width: 3%; vertical-align: top;">&#160;&#160;</td>
              <td rowspan="1" style="width: 70%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td colspan="2" rowspan="1" style="width: 3%; vertical-align: top;">
                <div style="line-height: 1.25;">THINKEQUITY LLC</div>
              </td>
              <td rowspan="1" style="width: 70%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 3%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 27%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 70%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
                <div style="line-height: 1.25;">By:</div>
              </td>
              <td style="width: 27%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">/s/ Eric Lord</div>
              </td>
              <td style="width: 70%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 3%; vertical-align: top;">&#160;</td>
              <td style="width: 27%; vertical-align: top;">
                <div style="line-height: 1.25;">Name: Eric Lord</div>
              </td>
              <td style="width: 70%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 3%; vertical-align: top;">&#160;</td>
              <td style="width: 27%; vertical-align: top;">
                <div style="line-height: 1.25;">Title: Head of Investment Banking</div>
              </td>
              <td style="width: 70%; vertical-align: top;">&#160;</td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-variant: small-caps;">[Signature Page]</div>
        <div style="text-align: center; line-height: 1.25; font-variant: small-caps;">[ELTEK&#160; &#8211; Underwriting Agreement</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="line-height: 1.25; font-variant: small-caps;"><br>
        </div>
      </div>
      <div style="text-align: center; line-height: 1.25;"><font style="font-weight: bold;"><u>SCHEDULE 1</u><br>
        </font><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="width: 75%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;" id="zfc77006f0f2a4e7ba45e087c19fe9edf" class="cfttable">

          <tr>
            <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); width: 68%;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">Underwriter</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">Total Number of Firm Shares to be Purchased</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">Total Number of Option Shares to be Purchased if the Over-Allotment Option is Fully Exercised</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 68%;" rowspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell" rowspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell" rowspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 13%;" colspan="1" class="cftnumcell" rowspan="1">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell" rowspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell" rowspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell" rowspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 13%;" colspan="1" class="cftnumcell" rowspan="1">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 68%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">ThinkEquity LLC</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 13%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              <div style="line-height: 1.25;">625,000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 13%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              <div style="line-height: 1.25;">0</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 68%;" rowspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell" rowspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell" rowspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 13%;" colspan="1" class="cftnumcell" rowspan="1">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell" rowspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell" rowspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell" rowspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 13%;" colspan="1" class="cftnumcell" rowspan="1">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 68%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-weight: bold;">TOTAL</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 13%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              <div style="line-height: 1.25; font-weight: bold;">625,000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 13%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              <div style="line-height: 1.25; font-weight: bold;">0</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Sch. 1 - 1<font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;"></font></div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
      </div>
      <br>
      <div style="text-align: center; line-height: 1.25;"><font style="font-weight: bold;"><u>SCHEDULE 2-A</u><br>
        </font><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">Pricing Information</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">Number of Firm Shares:&#160; 625,000</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">Number of Option Shares: 0</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">Public Offering Price per Share:&#160; $16.00</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">Underwriting Discount per Share:&#160; $0.96</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">Proceeds to Company per Share (before expenses):&#160; $15.04</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Sch. 2 - 1</div>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;"><u>SCHEDULE 2-B</u></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">Issuer General Use Free Writing Prospectuses</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">None.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25">
          <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Sch. 2 - 2<br>
          </div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
        </div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;"><u>SCHEDULE 2-C</u></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">Written Testing-the-Waters Communications</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">None.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25; text-align: center;">Sch. 2 - 3<br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <br>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;"><u>SCHEDULE 3</u></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">List of Lock-Up Parties</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25;">Officers and Directors and Affiliates:</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z86da4685928b4b08bad76d1c8522606a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">1.</td>
            <td style="width: auto; vertical-align: top;">
              <div>Yitzhak Nissan</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z3976d20b7d344e7096369a791f046cd4" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">2.</td>
            <td style="width: auto; vertical-align: top;">
              <div>Mordechai Marmorstein</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z32ca0740e5f04e4ba70985af7d978e6a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">3.</td>
            <td style="width: auto; vertical-align: top;">
              <div>David Rubner</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z7a5070abbb87431d931bffd6c66541c8" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">4.</td>
            <td style="width: auto; vertical-align: top;">
              <div>Erez Meltzer</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z981f4abeb02d4ba0ab2f236dad55ca61" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">5.</td>
            <td style="width: auto; vertical-align: top;">
              <div>Gad Dovev</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="zfdaa10b2e0394f578cfe2831428e94b2" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">6.</td>
            <td style="width: auto; vertical-align: top;">
              <div>Ilana Lurie</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z6396473856c4478a8001ea434d040554" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">7.</td>
            <td style="width: auto; vertical-align: top;">
              <div>Revital Cohen-Tzemach</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z2bf0f4bdab6a49f085e29b84de4283b6" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">8.</td>
            <td style="width: auto; vertical-align: top;">
              <div>Eli Yaffe</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="zd0278c2f74704c8bb984720d35e7425a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">9.</td>
            <td style="width: auto; vertical-align: top;">
              <div>Ron Freund</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="zcf374df527f44aeea0d52cf0652a877a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">10.</td>
            <td style="width: auto; vertical-align: top;">
              <div>Oriel Sallary</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="ze699feefd89445fe9216c11833c03e45" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">11.</td>
            <td style="width: auto; vertical-align: top;">
              <div>Shlomi Kisluk</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z75e37a96edd643a0b406120e94b0eb9f" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">12.</td>
            <td style="width: auto; vertical-align: top;">
              <div>Yitzhak Zemach</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="zc10180b3afac4460b5eea92208164115" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">13.</td>
            <td style="width: auto; vertical-align: top;">
              <div>Sagi Balter</div>
            </td>
          </tr>

      </table>
      <div class="BRPFPageFooter">
        <div style="text-indent: 211.8pt; line-height: 1.25;"> <br>
        </div>
        <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
          <div style="text-align: center; line-height: 1.25;">Sch. 3 - 1</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
        </div>
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;"><u>EXHIBIT A</u></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25;"><font style="font-weight: bold;">Lock-Up Agreement<br>
        </font><br style="line-height: 1.25;">
      </div>
      <div style="text-align: right; text-indent: 36pt; line-height: 1.25;">&#160;[&#8226;], 2024</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">ThinkEquity LLC</div>
      <div style="line-height: 1.25;">17 State Street, 41st Floor</div>
      <div style="line-height: 1.25;">New York, NY 10004</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">As Representative of the several Underwriters named on Schedule 1 to the Underwriting Agreement referenced below<br>
        <br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">Ladies and Gentlemen:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The undersigned understands that ThinkEquity LLC (the &#8220;<font style="font-weight: bold;">Representative</font>&#8221;), proposes to enter into an Underwriting Agreement (the &#8220;<font style="font-weight: bold;">Underwriting Agreement</font>&#8221;) with Eltek Ltd., an Israeli corporation (the &#8220;<font style="font-weight: bold;">Company</font>&#8221;), providing for the public offering (the &#8220;<font style="font-weight: bold;">Public Offering</font>&#8221;)



        of ordinary shares, par value NIS 3.00per share, of the Company (the &#8220;<font style="font-weight: bold;">Shares</font>&#8221;).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">To induce the Representative to continue its efforts in connection with the Public Offering, the undersigned hereby agrees that, without the prior written consent of the
        Representative, the undersigned will not, during the period commencing on the date hereof and ending 60 days after the date of the final prospectus (the &#8220;<font style="font-weight: bold;">Prospectus</font>&#8221;) relating to the Public Offering (the &#8220;<font style="font-weight: bold;">Lock-Up Period</font>&#8221;), (1) offer, pledge, sell, contract to sell, grant, lend, or otherwise transfer or dispose of, directly or indirectly, any Shares or any securities convertible into or exercisable or exchangeable
        for Shares, whether now owned or hereafter acquired by the undersigned or with respect to which the undersigned has or hereafter acquires the power of disposition (collectively, the &#8220;<font style="font-weight: bold;">Lock-Up Securities</font>&#8221;)
        other than with respect to Shares currently subject to an effective 10b5-1 plan, and with respect to Nistec, other than with respect to 50,000 shares which may be sold during the period March 12 to 14, 2024 at prices no less than $1.00 above the
        offering price of the Shares in the Public Offering, (2) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of the Lock-Up Securities, whether any such transaction
        described in clause (1) or (2) above is to be settled by delivery of Lock-Up Securities, in cash or otherwise; (3) make any demand for or exercise any right with respect to the registration of any Lock-Up Securities; or (4) publicly disclose the
        intention to make any offer, sale, pledge or disposition, or to enter into any transaction, swap, hedge or other arrangement relating to any Lock-Up Securities.&#160; Notwithstanding the foregoing, and subject to the conditions below, the undersigned
        may transfer Lock-Up Securities without the prior written consent of the Representative in connection with (a) transactions relating to Lock-Up Securities subject to pre-existing 10b5-1 plans, (b) Lock-Up Securities acquired in open market
        transactions after the completion of the Public Offering;<font style="font-style: italic;">&#160;</font><u>provided</u> that no filing under Section&#160;16(a) of the Securities Exchange Act of 1934, as amended (the &#8220;<font style="font-weight: bold;">Exchange
          Act</font>&#8221;), shall be required or shall be voluntarily made in connection with subsequent sales of Lock-Up Securities acquired in such open market transactions; (c) transfers of Lock-Up Securities as a <font style="font-style: italic;">bona
          fide</font> gift, by will or intestacy or to a family member or trust for the benefit of a family member (for purposes of this lock-up agreement, &#8220;family member&#8221; means any relationship by blood, marriage or adoption, not more remote than first
        cousin); (d) transfers of Lock-Up Securities to a charity or educational institution; or (e) if the undersigned, directly or indirectly, controls a corporation, partnership, limited liability company or other business entity, any transfers of
        Lock-Up Securities to any shareholder, partner or member of, or owner of similar equity interests in, the undersigned, as the case may be; <u>provided</u> that in the case of any transfer pursuant to the foregoing clauses&#160;(b), (c) or (d), (i) any
        such transfer shall not involve a disposition for value, (ii) each transferee shall sign and deliver to the Representative a lock&#8209;up agreement substantially in the form of this lock-up agreement and (iii) no filing under Section&#160;16(a) of the
        Exchange Act shall be required or shall be voluntarily made.&#160; The undersigned also agrees and consents to the entry of stop transfer instructions with the Company&#8217;s transfer agent and registrar against the transfer of the undersigned&#8217;s Lock-Up
        Securities except in compliance with this lock-up agreement.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Ex. A - <font class="BRPFPageNumber">1</font></div>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If (i) during the last 17 days of the Lock-Up Period, the Company issues an earnings release or material news or a material event relating to the Company occurs, or (ii) prior to
        the expiration of the Lock-Up Period, the Company announces that it will release earnings results or becomes aware that material news or a material event will occur during the 16-day period beginning on the last day of the Lock-Up Period, the
        restrictions imposed by this lock-up agreement shall continue to apply until the expiration of the 18-day period beginning on the issuance of the earnings release or the occurrence of such material news or material event, as applicable, unless the
        Representative waives, in writing, such extension; provided, however, that this extension of the Lock-Up Period shall not apply to the extent that FINRA has amended or repealed NASD Rule 2711(f)(4), or has otherwise provided written interpretive
        guidance regarding such rule, in each case, so as to eliminate the prohibition of any broker, dealer, or member of a national securities association from publishing or distributing any research report, with respect to the securities of an Emerging
        Growth Company prior to or after the expiration of any agreement between the broker, dealer, or member of a national securities association and the Emerging Growth Company or its shareholders that restricts or prohibits the sale of securities held
        by the Emerging Growth Company or its shareholders after the initial public offering date.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The undersigned agrees that, prior to engaging in any transaction or taking any other action that is subject to the terms of this lock-up agreement during the period from the
        date hereof to and including the 34<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> day following the expiration of the initial Lock-Up Period, the undersigned will give notice thereof to the Company and will not consummate any such transaction or take any such action unless it has
        received written confirmation from the Company that the Lock-Up Period (as may have been extended pursuant to the previous paragraph) has expired.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If the undersigned is an officer or director of the Company, (i) the undersigned agrees that the foregoing restrictions shall be equally applicable to any issuer-directed or
        &#8220;friends and family&#8221; Shares that the undersigned may purchase in the Public Offering; (ii) the Representative agrees that, at least three (3) business days before the effective date of any release or waiver of the foregoing restrictions in
        connection with a transfer of Lock-Up Securities, the Representative will notify the Company of the impending release or waiver; and (iii) the Company has agreed in the Underwriting Agreement to announce the impending release or waiver by press
        release through a major news service at least two (2) business days before the effective date of the release or waiver.&#160; Any release or waiver granted by the Representative hereunder to any such officer or director shall only be effective two (2)
        business days after the publication date of such press release.&#160; The provisions of this paragraph will not apply if (a) the release or waiver is effected solely to permit a transfer of Lock-Up Securities not for consideration and (b) the transferee
        has agreed in writing to be bound by the same terms described in this lock-up agreement to the extent and for the duration that such terms remain in effect at the time of such transfer.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">No provision in this agreement shall be deemed to restrict or prohibit the exercise, exchange or conversion by the undersigned of any securities exercisable or exchangeable for
        or convertible into Shares, as applicable; <u>provided</u> that the undersigned does not transfer the Shares acquired on such exercise, exchange or conversion during the Lock-Up Period, unless otherwise permitted pursuant to the terms of this
        lock-up agreement.&#160; In addition, no provision herein shall be deemed to restrict or prohibit the entry into or modification of a so-called &#8220;10b5-1&#8221; plan at any time (other than the entry into or modification of such a plan in such a manner as to
        cause the sale of any Lock-Up Securities within the Lock-Up Period).</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25">
          <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Ex. A - 2</div>
        </div>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The undersigned understands that the Company and the Representative are relying upon this lock-up agreement in proceeding toward consummation of the Public Offering.&#160; The
        undersigned further understands that this lock-up agreement is irrevocable and shall be binding upon the undersigned&#8217;s heirs, legal representatives, successors and assigns.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The undersigned understands that, if the Underwriting Agreement is not executed by January 31, 2024, or if the Underwriting Agreement (other than the provisions thereof which
        survive termination) shall terminate or be terminated prior to payment for and delivery of the Shares to be sold thereunder, then this lock-up agreement shall be void and of no further force or effect.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Whether or not the Public Offering actually occurs depends on a number of factors, including market conditions.&#160; Any Public Offering will only be made pursuant to an Underwriting
        Agreement, the terms of which are subject to negotiation between the Company and the Representative.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">
        <table cellspacing="0" cellpadding="0" border="0" id="zd1cbb06156d44196bb30aae8d0c21454" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
              <td style="width: 6%; vertical-align: top;" rowspan="1" colspan="2">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Very truly yours,</div>
              </td>
              <td style="width: 20%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
              <td style="width: 6%; vertical-align: top;">&#160;</td>
              <td style="width: 24%; vertical-align: top;">&#160;</td>
              <td style="width: 20%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
              <td style="width: 6%; vertical-align: top;">&#160;</td>
              <td style="width: 24%; vertical-align: top;">&#160;</td>
              <td style="width: 20%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
              <td style="width: 6%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0);" rowspan="1" colspan="2">
                <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">(Name - Please Print)</div>
              </td>
              <td style="width: 20%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
              <td style="width: 6%; vertical-align: top;">&#160;</td>
              <td style="width: 24%; vertical-align: top;">&#160;</td>
              <td style="width: 20%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
              <td style="width: 6%; vertical-align: top;">&#160;</td>
              <td style="width: 24%; vertical-align: top;">&#160;</td>
              <td style="width: 20%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
              <td style="width: 6%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0);" rowspan="1" colspan="2">
                <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">(Signature)</div>
              </td>
              <td style="width: 20%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
              <td style="width: 6%; vertical-align: top;">&#160;</td>
              <td style="width: 24%; vertical-align: top;">&#160;</td>
              <td style="width: 20%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
              <td style="width: 6%; vertical-align: top;">&#160;</td>
              <td style="width: 24%; vertical-align: top;">&#160;</td>
              <td style="width: 20%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
              <td style="width: 6%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0);" rowspan="1" colspan="2">
                <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">(Name of Signatory, in the case of entities - Please Print)</div>
              </td>
              <td style="width: 20%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
              <td style="width: 6%; vertical-align: top;">&#160;</td>
              <td style="width: 24%; vertical-align: top;">&#160;</td>
              <td style="width: 20%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
              <td style="width: 6%; vertical-align: top;">&#160;</td>
              <td style="width: 24%; vertical-align: top;">&#160;</td>
              <td style="width: 20%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
              <td style="width: 6%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0);" rowspan="1" colspan="2">
                <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">(Title of Signatory, in the case of entities - Please Print)</div>
              </td>
              <td style="width: 20%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
              <td style="width: 6%; vertical-align: top;">&#160;</td>
              <td style="width: 24%; vertical-align: top;">&#160;</td>
              <td style="width: 20%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
              <td style="width: 6%; vertical-align: top;">&#160;</td>
              <td style="width: 24%; vertical-align: top;">&#160;</td>
              <td style="width: 20%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; padding-bottom: 2px;" colspan="1">&#160;</td>
              <td style="width: 6%; vertical-align: top; padding-bottom: 2px;">
                <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Address:</div>
              </td>
              <td style="width: 24%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><br>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; padding-bottom: 2px;" colspan="1">&#160;</td>
              <td style="width: 6%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
              <td style="width: 24%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><br>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; padding-bottom: 2px;" colspan="1">&#160;</td>
              <td style="width: 6%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
              <td style="width: 24%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><br>
                </div>
              </td>
              <td style="width: 20%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25"> <br>
      </div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25">
          <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Ex. A - 3</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
        </div>
      </div>
      <br>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;"><u>EXHIBIT B</u></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">Form of Press Release</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">[]</div>
      <div style="line-height: 1.25; font-weight: bold;"><br>
        [Date]</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">[] (the &#8220;Company&#8221;) announced today that ThinkEquity LLC, acting as representative for the underwriters in the Company&#8217;s recent public offering of&#160; _______ shares of the Company&#8217;s common stock, is
        [waiving] [releasing] a lock-up restriction with respect to _________&#160; shares of the Company&#8217;s common stock held by [certain officers or directors] [an officer or director] of the Company.&#160; The [waiver] [release] will take effect on&#160; _________,
        202[ ], and the shares may be sold on or after such date.&#160;&#160;</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">This press release is not an offer or sale of the securities in the United States or in any other jurisdiction where such offer or sale is prohibited, and such securities may not
        be offered or sold in the United States absent registration or an exemption from registration under the Securities Act of 1933, as amended.</div>
      <div class="BRPFPageFooter"><br>
      </div>
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Ex. B - 1<br>
          <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;"></div>
      </div>
    </div>
    <div> <br>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0H!W # 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **,T4 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 444AZ4 +14:YSS4E !1110 4444 %%%%
M !1110 4444 %%%% " 4M%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4A.*6B@ %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !29JO=W:6R;G.*QY/%=E$^UG&?K4N21+DD=!FC/%<
M\?%MCC[X_.@>++'^^/SI<Z[BYX]SH,TN:Y__ (2NQ_OC\Z3_ (2VQ_OC\Z.=
M=Q<\>YT.:6N=_P"$ML?[X_.C_A+K'^^/SI\\>X>TCW.BI,USW_"76/\ ?'YT
M?\);8_WQ^='/'N'M(]SH<\TM<Y_PEMC_ 'Q^=+_PEUC_ 'Q^=+GCW#VD>YT)
M- -<Y_PEMEG[X_.C_A+[ '&\?G1SQ[A[2/<Z2BLFQURWOVQ&P-:HZ52:>Q:D
MGL+1113&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MUZPO2O(/AV"+W\:]?'2O6H/W3W,,[PN+11170= 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <GXRYLS]*\@O
M&(F(KV#QES9GZ5X_>$>:17FXS<\G';E>BE4@=:#7FH\H2BCJ:=D8I@ .!BDI
M,X-**8+<3OFE)S1WS02#TJ$#W"E#$<4VGJ0!S5/88P^M(1\N:4]<T?PTX[@M
MSM/AX2;W'O7KHKR/X>$&]X]:]='2O:P_P'T&%_ABT445T'4%%%% !1110 44
M44 %%%% !1110 E)GFFM(H[TSSD]147)<D3T5$)E]11YR^HJN9!S(EHJ+SU]
M10)U/<470<\26BH_.7U%)YR^HHYD',B6BH_-7U%)YR^HI<R'S(EHJ+SE]109
MU]11S(7,B0F@5&)5/<4GG+NQD4<R#F1-3<\TX=**;*$%+1130!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2-]TTM(WW30!YG
MXP8[I!7G /[UOK7I/B\C=(*\V/RRMGUKPZ_QL\#$_&QQI*4'G-*2#TK#J<8F
M[M244X$8I!L(#B@G-(:!UI[ %+NXQ2D@]*;0&X4 XIRD <TTT;@!.:CY,J_6
MI!UII(,J8]:<7J-?$CV[P7QI"?2NGKF/!G_((3Z5T]>]2^!'TM'X$%%%%:&H
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I&^Z:6D;[IH \U\7@;
MI#7FWWI6^M>C^,%.Z0UYN/\ 6M]:\2O\;/ Q/QL=C%'>EQDT8Q7.SC%P,4VC
M)I=N>: !1GK0:2@<T; '>G8&*0KBDYI %*O- &:3I3W 5@*B/$J?6I.O%,*X
ME3/K3B]1Q^)'M_@O_D$)]*Z>N8\&?\@A/I73U[U+X$?2T?@04445H:A1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(WW32TC?=-
M'F?C#=NDKS<?ZUOK7I/B]OG<5YLQVRM]:\.O\;/ Q/QL>:3% />E)S6'4XQ,
MFC!HIP; Q2 ;THZT4#CFGZ &/6C)I2V:2@ P31TI0<4AH "<U'@^:F?6I/>F
MELRI]:<=QKXD>W>#/^00GTKIZYGP9_R"$^E=-7O4O@1]+1^!!1116AJ%%%%
M!1110 444E "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M30 M%)FD+@#DT"NAU%0-=0K]YP/QJ%M2MA_RU7\ZER0G)(NTA-8EWK<,7W9
M?QK.E\3(@R''YU#K11E*O!:'6 TN17!3>,=G1JIMXZ<'K2=> ?6('I.:0UY;
M)\0)5; S49^(4WO2]O 3Q-,]6!I<UY0?B'-CO2I\0ICUS3]O :Q$#U;-%>8Q
M>/9&/-78_&A;JU'MX!]8@>@9%&:XV'Q6K]7'YUI6^O128S(/SIJM!B^LP.AH
MJA'J=NP_UJ_G5A;R!ND@/XU:DF;*:9/13!(K=#FGU15PHHHH **** "BBB@
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M ]Q*<".]-IRJ"*;V 3C/-#$;:0CG%-/ Q3CN.*]X[?X>D?;>/6O75Z5Y#\/
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MBIBGTT,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBD/2@!:,T@II..M*XKCB:KSW2P*2Q%4-3U:&TB;]X
MP]Z\UUWQC/N98R2*YJE91.>KB(P.NUGQC;VZM&&&ZO/]4\0SW;'R9"!]:PY[
ME[]_,<G)IBIY=<53$29YM;%.0LDEU(V9')%,\LGFI/-+<4TD@XKEE49PRJML
M!M%/WC&*81QD4*O&36=[D\S8A!-*HQR>E.IN<G%6D/E0YB&^[3<4'Y>E*3QF
MFTA\J'=N:80<THYZTM*R%RH: <TK<]*0DYI12Y0:0W!IZ\#FD/2F@D]:+ XH
M4@Y]J7!I Q)Q020<"G9; HBXS1G'%!X'%)C(SWI\J&D!S1Y;&D!/>G[R!BH:
ML)H;L:DVTXN:16R>:+M&;N@X'UH2XN(&RCD4C\'BECRYPU:QJ,UA-HZ31_$T
MMM(OFR$@>]>C:3XIM[Q54,,UXK)%W%6].U*6Q<;2:Z(8EH]"EBFCZ!BE$J[@
M:EKS?0/%;2.L<KX'UKT"UNH[F,,C \5Z%*HIK0]*G54UH6J*8"<T^MDS9.X4
M444QA1110 4444 %%%% !1110 4444 <IXR_X\S]*\>O ?.)KV'QES9GZ5X_
M>D^<17FXS<\G';E<#-&,4 XH)KSD>4%+M[TT4[=VH **:<YIU +<3O2D$4>]
M)DGK4H;W%I0">E)2@D=*I[ -/I1CY:#US03\M..X+<[3X=@B]Y]:]>'2O(?A
MX2;WGUKUX=!7M8?X#Z'"_P ,6BBBN@Z0HHHH *1ONFEI&^Z:&!POBXC[-(*\
MEZ3/GUKUKQ:H^SR&O)&SYS?6O,Q#L>/B79L>4)&10(6/-*'/2@S%>!7F.;N>
M9*H[C>0<4]2#Q49);FD&X&M4[HU4M![IMYIJL<^U2 [Q@U&1AJAF&[)#STIM
M'(I>U.UC2V@E!%%.'/6I;)$%#9/2@\=*,U2>@TQ #0>.M&:0DD\T,3W'=J3G
M-**:V<\4(;5Q64R#"]:: R_*33T;9S2%LMNI/<E)H3;LY-*&!^E./SCFFLH4
M54I:#<A".>*?@,N!UHC 84F=K4*3L4I,;M*\&@ BE8D\TW)-)-@.*D\T@4TN
MX]*"Q'2LW)W,GN '/-.)"G%,R>M)R3S6T7H:QV)CC;FHV8;#BGXRO-1.,#BL
M6]2$M3L?A\/],/UKU^,' KR/X?C%UQZUZ[%]VO;PGPZGNX->Z24445V'>%%%
M% !1110 4444 %%%% "$XH!H(S3'D2)<L<"@-!Y-4+S5(K1"S$<5C:WXABM4
M/E2 GV-><ZOXIGN"R G%<U6LH'+6Q"AHCJM:\71N&6-\'ZUP-WJUW+.S>:=I
M]ZS7FDD;+9YIV3MK@J8AO8\NKBFQTC33'+,34?EYH\QAP!2@MUQ7,ZC9QNJV
M*(R!2?,.IIV\TY?FZUBU=ZBU&@9Y-.QCI3"Q#8[4,Q[5LDK%[ S9X%"@]Z;C
MO3E)[TK(38I%)@TN31S2:0M! /2EHHHL F*6@TT$YHL ;232LIQQ1N(-/SQQ
M3Y45?0B&<X-2#WII'>@9[TK(35Q2*!3<G..U!)!XI-V#E%*TFS-.YQ2;B#1[
M1H:T#8R<@U9@U"Y@(VR$ 5 7)'-,R2<4XU&4JC1W/A_Q7]GPLSY^IKOM/UV&
M]"A2,FO"57:<@UK:?K\]BXVD\5W4<0UN=M#$VT9[RK<=:DKC?#7B1;V$>>X#
M>YKKHY Z@@Y%>E":DM#U(33V'FD!%.I ,59J+1110 4444 %%%% !1110 44
M44 %(WW32TC?=- 'F?C!3NDKS<?ZUOK7I/B\G>XKS9N)6QZUX=?XV>!B?C8_
MJ:,8I >]+G-8=3C$R:7;FDP:7=BD E'6BCI3] %VXI,FE+9I.:0"XS2=*4'%
M)UI^H!UXIFW$J9]:?TYIF[,JY]:<=QQ^)'M_@S_D$)]*Z>N8\&?\@A/I73U[
MU+X$?2T?@04445H:A1110 4444 %%%% #2#FG"BFL<"AL&QDL@C4L>U<3XJU
M]88V56Q6OX@UB.VM) '&['2O'-4U.6^G8.3C-<E>K961P8FO9616O)7N+HRD
MY4FD$B;>E-7E<&E$:CO7E5)7/&J5&V-X9J>4^7 ICC8,K3H7)'S5CS-&?,QB
M1LK9;I3F4YXZ4Z9CCBFJS%>:OFN5S.P"@C-+FC-/J T+CK1DBG$YIO6AB>X@
M4DY[5(_SK@4S=@8I8S@U%KD6NP4X&T]:<5P,FHY.#NHA,D\@4 G)K6$#HA3'
MV=M)>77EKGK7J_A/P\EO$&EC!/N*R/"WAQ=Z3LO)KTFW@6% %]*]'#TK.YZ>
M%HV=R:-1&@51@"GT@I:[STD%%%% PHHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *0TM122+&N6.!2;L)L5I J
MDFN>UGQ'#8QMDBJ/B'Q MJK+&_ZUYAJFKS7TK*Y.VN:K72T1QU,5%:%G7?$$
ME_<DQN=M8C$R<MS0L:XSWIXQWKS*E2[N>16J-NX(H7FAOWG2DSSCM1]WI6#D
M<S;8!-O-*6!%&[(Q0%HY;E<HQ>#S3STR*!M[TC=<#I4VL#5A!S1CG%/7 IQ
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M-7+%%%%:FX4444 %%%% !1110 4444 %%%% ')^,N;,_2O(+Q@)2*]?\9?\
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MIC<=*>I700FE!V\FA>>M*PXI-F5[NP!LG-*Q!Z4@7BEP*>IJD)N&*56 ZTW
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MK04RM,7<IJ>9WLB;L:BD-4YZ8I&QMR.M1;FSS5*[*46QR1E&R:D+@4U5DDX
MJ46%PPX4U2@RO8LA+;^E-*FK(TVY'1#0VG7>.$-'(T/V+*Z@C@U(4P,TGV2Y
M7EE--;>HPU'*P=-B8IR_/Q4:M\W/2IG*JOR]:3B1R.XGW>*:>:8K%FYJR$&,
MTMAW:(2A4;J1<OS2DMOPWW:=P!\M)RN2]0SNXIN"#BDY!XIXZ<]:1.PT@BC:
M>M'.>:7)II#W <4=:3!/2D)(''6KN,?Y9QFD YYIR,=GS=:A!;?[5'4:9JZ1
MJ;VM\@#$+FO9=$U1;R! #SBO"L;?G'45V/@[6FCFVR-@9KT,/5L['HX6LXL]
M>/-"BJ]G.L\(<'-60:]-,]A.Z%HI.]+3&%%%% !1110 4444 %(WW32TC?=-
M 'FGB]3O<UYNPW2MCUKT?Q@6W25YN/\ 6M]:\2O\;/ Q/QL=C%%*>:3%<[W.
M07;WI*7=28-'00H&:",4F<49S1Z@%+MXS28I=QZ4@$H S1@FCI3 4C'%1'B5
M/K4W6H6R95^M5%79I3C=GM_@O_D$)]*ZBN6\%_\ ((3Z5U%>[25HH^BI/W$+
M1116AJ%%%% !1110 A-1L=HR33VP!DUS'B76UM+5O+?YA42ERK4SJ245=F5X
MK\2I:;H >3Q7EUS*\UPTA8D$U9U2^?4)B\AR<U04GH>E>96J7=SQZU7F%+;A
MM%.AB*')IQ0;<CK3$<DX:N&4KG%*0YASFF]:4DY]J!0DR4&*"*&]J09[U0VM
M VD4X+QFD)I"3MXI;"%*%^G:D,@4;>])&[ T\H#\U#!LC$;,<YJ7[@YIH8C@
M4%N/FJ>7H+DOL(W/(J[I6DR:M,$0'@U7L[:6YN55%RI->K^%=!2T"R%<$^U=
ME"FV['=AJ+D:7AS0TL+10Z#<.]=(!@8I%4*N!2BO7A'E1[<(J*L+1115%A11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %9^J7JVEJTA/05=D<*I->;^+=>"F2W#\^F:RJS448UJBC$YO
MQ/KYOY2JMT-<Y_#N/6FL2\C,W<THZ\]*\6M/4^?K3O( -_S>E*9-PVU(I4#
MII5<Y'6L8RN1<:!@8I>E)GUH'-4V G>E)S11QVHL*W4,T!\<4=J;WS2=P:N/
MQY?S&F^<'. *?N5QBF; IS46;9FHML<8LC-1&0_< J=(Y+DA8AFNJT/PM).Z
MM-'^E==*G<[:5)LYJRLI)SC:>:Z*S\&R7(#8/->AV7A>TB53L&?I6U!8Q0@!
M1TKLCANIVPP;>K/.H/ 3J02*V;;PB(P,J*[4*!2XKH6'@CKCA8(Y@>&D"XV#
M\J8?#"'^$?E75T5?L8E^P@<C)X65EP%%8M]X%:<_+Q7I%(12]A EX>!X[<^
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MZRUS=.FXXS6YXO\ $'FR%8'R.]<-*?-._P#B->;7K<VAY.*KWT&C)I2<4Z(
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MG';QA0HX]J?;0B&-5 Z"I^]>K3IJ*/8I4E! *=116QT!1113 **** "BBB@
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MUJII\$ES>+'C()KUKPUH26T:N4QD5TTJ5V=U"BY,ET+PVEK$I91Q7510K&N
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M-_D-<]:KRHYZ]51B9_B+7'U.5DR>#6"B$#)IV06+'J:<& /M7E5)MGA59\S
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M@ IVT8S28Q29-( I5&:,9I.E,!2,5$QQ*OUJ3K414K*A/K3C:Z+AN>X^"O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ML>E(QSTI0PQCO31"6H@)6E]^]&0.M(#SGM0T-H3))IV3B@XS2DC%(8E*K;:
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MWX6;.CQ?2O!D7%W'_O"O=O"W_()B^E>G@F>IETM6;]%)2UZ1[ 4444 %%%%
M!1110!R?C+_CS/TKR"\ \TFO8/&7%F?I7C]Z"9B:\W&+4\G';D"@'K0>*2BO
M-1Y04[ Q30*.:8!2TFTGFEHN"W$[TIP.E'M2;2.M2@>X4]0".:;2A2:I[#&G
MKBC^&@^E(3\N*<=P6YVWP\ %[QZUZX!Q7D7P\!%[SZUZ\.E>UA_@/H,+_#%H
MHHKH.H**** "BBB@ HHHH **** "JM__ ,>K?2K55=0YM6^E3+8F?PL\@\6
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M#=3OH*X8SQ1@#B@#F@\'%)!<-H%&T9S2D8HQQFB^H7$*@]:,=J!\U&.:&PN
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MVD*I.R_,:[I$"  5'9PI#"J@#BK->S3IJ*/?I4U&(@%+116IL%%%% !1110
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M@<ZU$1ZU=+XT;4/C1[Y9?\><?^[4]5['_CTC_P!VK%>^MCZ1;!1113&%%%%
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MR'X>-F]Q[UZZ#7M8?X#W\+_#'4445T'4%%%% !1110 4444 %%%% !574/\
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MGV2]#$XYKV33KL74(8'/%>OAZEXV/<PE1.-B_124M=9VA1110 4444 %%%%
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M6OFDQT-<63SM]*\7$QLSPL4K2L.&<>U(>>E(&)XIWW*Y$]3A>HT#FEYI">]
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MI->;C-SR<=N5Z*51F@\5YIY0E%'>G8&*=P 8QS2=Z2EHL"W$[TXX[4W'-*0
M.*2![B4]2 .:93@ :;V :>M-/2GXR<4, %Q3CN.+]X[/X>$?;./6O70>*\C^
M'B@7OXUZX!Q7M8?X#Z#"_P ,=11170=04444 %%%% !1110 4444 %5=0_X]
M6^E6JK7PS:L/:E+84MCQ[Q407;'K7**1T[UUGB]!&S$>M<I&HV;N]>)76I\_
MB'J/&%ZTF1F@?/UHP,XKG2.2X$@GBC-(1@\4M,I;"@C%' ZT #K1][K4]21O
M4\4M&,45JF"0I(QBD&*"HQFD6L^HXL<QP.:MZ <ZQ']:J;0_!JQI)\G4XV[
MUI3^(VIR7,>^:>?]$C^E7:P]#O%GMT .<"MRO=I_"?0TI<T;A1115F@4444
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M"")4SZT\G/-,))E3/K1&]T-?$CV_P7SI"?2NGKF?!?&D)]*Z:OH*?P(^EH_
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MGTAZ4F)['F'Q%CQ%Q7G$+87'>O6/'EN)8>E>621B-\5Y&*TD>%BU:8 T9P:
M*!UKD6QQO8"<GBEI#@'BC-"!"&@&G<8I%QGFDQ7$[T$TO&ZA@*!W L,8I*7
MQ0,=Z+Z"B@52>E##;UH9BO2C[R\T1=M1RT&>:RR*R'&#7HGAGQA%%&ELY^8<
M5Y[&@YS1'_H\_F(>:Z*=5HZ<-6<6?0=GJ$=T@8$=*MB0$]:\4T[Q7<VY52Q
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M+*WUKTGQ>!ND->;?>E;/K7B5_C9X&)^-C@><TI(-)BD[USO<XPIP(Q1@8IM
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MMLWGXUZZ#Q7D/PZQ]N_&O7P.*]G#JT#Z##+W!:***Z#I"BBB@ HHHH ****
M"BBB@ HHHH 8PW*17G7B[1ODDG KT<BL?7K/[38NH&21652'-$PK0<XV/ MQ
M25E/K4F>,UHZWIK6,[%EQDUG*1MYKQZT;,\.O3Y1#R<TH;=Q1P>E."@=*Y+N
M]CDN,_BQ3F7 IIZTX-GK6ERUL-I>M(>M'>E<I 32AL"G'&VF"@6X4#KFE%!J
MMP G-)NXQ12X&*+"L(#MH)[TO'>BG:P6&^]/#9XI*#@=*F3): MVI =M''XT
M$4UL/EL@)I5&1FFCKS4HQCBBXF[#<YXIDG"D4X]>*C<_+S4\KOH.#U.S^'G%
MY^->P1_=%>/_  \S]L_&O8(_NU[6%343W\&_<'T445UG:%%%% !1110 4QAF
MG9HZT-":,?5],2^MB@49KRCQ#H#V,K$*:]NVBL;5]'BO(F++DXKFJTE)7.>M
M2YD>";SOVD=*F##&*Z76O#DEM([HG%<M(K0R;6X->5.FT['A5*;C(<<TY7"]
M129&*0 %N:S:,VA[$2<CBF%N,4CY!^6EP-OO2N18%; Q1FFXIRX[T-C2L'O0
M#FE/7VIIQVJ;E\R0AY.*<#MHXQ[T#&.:>IDW=BYQS3"<G-*.OM2D#/%#&O,-
MV1BC=QB@X XI0!BFFA]!%XH- Q1Q330["=:=24A([57,AJ+$+<XIZ\4T =Z=
MQ0Y(' 1NM-ZTZCZ4KH5@W<8HW8XH.,4 #'-2VA-60@.#FG=>:08SS2$\X'2D
M+8"=W%*#VH.,<4<8]Z+"U C;2YP,TT'/6E--+4U3T$SNHH%..".*<B;C=W:C
M[O-+C I.O6JNK%I: #3X/FO8O]X4WBB#_C]BQ_>%$+<PZ<;S/>_#G_()B^E:
M]8_AO_D$1?2MBO>A\*/I8?"@HHHJB@HHHH **** "D;[II:1ONF@#S'Q@_[Q
MQ7G.?WC?6O2/&"C>YKSCCS&^M>1B5[QX.)^-BT4O>BN,XQ2V1B@' Q2<4<46
M"P XHSSFBBBP6 G-&>,44<8HL%@!P* <'-'%%%@L!.:A8;I4^M3&H_\ EJGU
MJHZ,<5[Q[=X*&-(3Z5U%<SX,_P"00GTKIJ]VD[P1])1^!!1116AJ%%%% !11
M10 4444 --9.M:>+R C&>*U\4CJ&7!J)QYE9D2C=6/ _$.G-:7Y 4X!K,R"*
M]:\4:''+!),%^;%>33QM!<,&X ->37@XL\3$4^5C2:%;%+E2.*:*X^IQ[@WK
M0O/-+QWI>,<5=M!I("<BDSQB@D4<5(K" TIXYHX'6DZ_2FD4E<3=DT\'/%(
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M />G#WJMM08H'>E+9XJ,YSQ3CTXJ.>XD]1">U(1BEX%*'4=:<GH:/84#BE(
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M3<\T .HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "@T4F:5P$&<TZF;J=FFV%[BTF**,T)@+2&@]
M*:&.Z@!PI:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH ***:S!5)/:E<"*XN%MUW,:RWU^!3U%8WBS6T@MF".-P[
M9KS5]>F<GDUR5*]G9'%6Q/([(]?_ .$CMO4?G3AXCMCQN%>,/K4W8FE36YAS
MDU$L58Q6-9[0WB&W7N*:?$=N!G(KQUM<F;N:C.MSG@$U4,2V5]<NSV9/$5O(
MX4$<UL0R+*@8=Z\C\/&>[D5B#UKU:P7;:H#UQ75"3DCJHU',MT4459N%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%(QH 6BD%!-
M !FN>U_78K"%T)Y(J]JM\MI;L^[!%>2>)M7:]F.&SS7-5K<J.6O74%8R=6U&
M:^O'^<E2:HJFT8-&"/F'6@$D\UY=2=]3Q:M3F=Q-N#DT;,G(I[\BFJ6 YZ5B
MI-G/S,3%7M*LC>W0B ZFJ:123S*L2DY/->I>%?#:111W#+AZZZ,&V=V&I.3-
M7PWH@L81YB\XKIT&W@=*:J84#TI^*]:"21[$8\JLA]%(*6J-@HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *AGE$<;,3T%/>0
M(NXGBN)\6>(!;(5B?KQUK.I-11G4FHQN8?BSQ*K&2W5N:X$.SL2QS4M[*UW<
M&5N<U&H %>/5G=G@5ZC<A4Z\TDC#=Q1T--."W-8Z,Q2N21G=07$C>2H^8TUR
M% V=:WO#NAR7=VDK(=N:UH4[LTH47*1M>#- );?*N>_->HVMNL$04#&*JZ9I
ML=G"NT8.*TZ]:%)1/>HT5!"8I:*0ULD;BT4@I:8!1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !2-TI:S]2OX[.(L[8XI-V1,I**NS.
MU[55MK-QN&0*\=U747U"=AN/!K3\4:[+<7;)&V4-<TO!+=S7EXBK=GCXC$-L
MDQM3!IF#FC+%N>E#9[5P/4X7[P_&\8J)U*\4_D#(I]M"\]PJXSDU<(MA!.]D
M6](TJ2]F'7K7L?AS2DM;-04&X5@^%=$\L*[IC-=W%&(Q@5ZF'I\JNSV<+1Y=
M6/Z#%.%)BEKL.\****8!1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%-+8&:J2:A%&V"U*Z)<DMRYFE
MJ@-3@/\ $*7^TH1SN%+F0N=%TT@.:J?VE 1]X4W^TH/[PI\T1\\2Z32@UGG4
MX,_>%6H+A)A\IJ%)-B4DV3T445H6%%%% !1110 444QW"#)H!NQ'=7"P0LY/
M05YAXO\ $'VE6B1L8XXK=\4:\ENKQ!\$^]>4W-R\]R[,>":X<16TLCSL57^R
MAA8ORQR::!NIP_2ER!TKRI-W/%J/4 >=M(WR&FDX.1303(V.].*N."'ESQ@9
MKM?"GAYKW9<,N,<U0\,:$UW=+YR90UZWINFQ6$(2)<#%>CAZ*W9ZN%H+XF6+
M2W6"!4"@8%6<4#%+7H)'IQ5D%%%%,H**** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ II;'6G5G:G>+;6S
M.3C%3)V)E)15V9VNZVNG*0".E>>W_BUC*Q!J#Q/K1NY&56SS7)D,YR:X*U?L
M>56Q',]#IU\62>IIY\6NPQDUS"Q9I2BUR.NS!U[(Z4>+9!QDTI\5/ZFN9V#;
M30N#S2]NS*.)9U \4/G.37>>#]4-^G)KQLCTKT_X=#"5UX:5Y'?A*G-(]&HH
MHKTCU HHHH ***0F@ )P,USOB'6%L;9F##(K1U*^2V@?)P<5XYXCUN2ZN9(@
M^1FN7$5>56./$UE%612UO4FU&X,FX]:S(CO.#3XT)0YJ,*4;(KRISN>/4FV2
ML-O%1XYJ0'<.>M(1M'-97N8?$!0;*OZ3IK74Z':2,U2LH9+NZ$:\Y->K>%?#
MXAC5I4YKLP]*[.W"T7*6IL:#I*V]LC;0#BNA XIL<8C0*.@I]>M&*BK(]N$%
M%60@%+115%A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>EUYK\4%W61^E 'AGA7_ )'*+_>KZTT__CPA_P!T5\F>%QM\91?[U?6>G_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'I0!!KEL9[9@!VKYI\>ZK<Z9JK1H2 #7U5*@>-@1VKYW^*?A=Y[V2Y5>!DT
M0_#'Q8_VD">3&3W-?0NGW2W=NLBG(-?%6D7SZ;J*H&(PV*^L_ %Y]JT&)RV2
M10!UU%%% "$A1DUYA\5/$+Z9IQ,#?-CL:]$U.?[/8R2?W17S3\2?$XU!Y+<-
MG!Q0!RUIXGOM3U%8R223ZU[_ /#JSN8D5Y5(R,\UX#X$TQIM<@<KE=U?7.D6
MT<.GP[4 .T4 :-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4F!Z4V25(U)9
M@*XWQ%XVATB)V#@X]Z .R9U09-4YM6MH?ON!7B-W\;$9F0?2N<U#XFRW>2N[
MGTH ^AV\2Z>O65?SJA?>(=)N(65Y5Z>M?-DOC.[DSC?5*3Q+?R9QYGZT /\
MB7+;RZVQMR"N>U=1\';@PW'![UY9J=S+<SEI<Y]Z]*^$RYN1]: /IRQD,D :
MK54=+&+5:O4 %%%% !1110 4444 %%%% !TK"UW54LH22V.*OZA>K;6[,2.!
M7DGBKQ ;YFB5CP<5SUJO*K(Y<36Y(Z&1KNIO=WK%6RI-9@ /)IB*3R3FI2N:
M\6<W)GSTZKE(;\N>>E#$@_)TI"F>*4?NA@\U T#;%7/>K>FV+WER@VY4FJ2P
MM.^%R>:]+\'Z#F%967IZUVT*7,SJP]%S9O>'= BLHUD"X)%=2JXIL40CC50.
M@J6O4A#E5CVZ=-05A *R]<(%F?I6K61K_P#QY'Z54OA+G\)XUXB8?:3]:R%(
MQS6IKR9N"?>L@+N&*\*NO>/G\3'4G&,<4Q@&I!\HVTNW;S6:.:-A@)0\5)Q(
M/GJ/^*GE<]*5[,F]F(F=^#]VGL@S\M(/F^6E^X,4^9V*4F(VW'%,(&,TNWG-
M2V=NUU<K$ >31!.3+IKF9<TC2VOYAA<\UZ]X?T=+6V3*X(K+\*>'19*LC#.>
M:[9$"# &*]?#T4E<]K#4$E=B@8&*6BBNP[@HHHH **** "HI_P#4M]*EJ.?_
M %+?2@#P_P"*;$VCBK/PC_X\!5?XJ)BS8U/\)#_H H; ]IB_U8I],B_U8I]
M%'4K%+NW=6&<BOG+XA^$'@GFN5B^7)YQ7TWUKG?%/AZ/6M/:$(,D>E 'Q0=U
MO/GH5->F?#OQ@]I?(EQ)A >YK)\>>#Y-!NV 4D$UQ$4DD$@*DJ0: /N/0]5B
MU.U62)@PQ7%?%+_CR/TKA?AGX[^R11VDC9)P.37:_$.=;S25D!!W+F@#Q/PK
M_P CE%_O5]::?_QX0_[HKY,\+KM\9Q#_ &J^L]/_ ./"'_=% %FBBB@#D/'/
M_(/;Z5\J^,/^0@WUKZL\;KNT]OI7RIXR7&HM]: /2/@9_P ?GXU](#I7S?\
M S_C\_&OI =* *NHY-A-CKM-?)GQ!@NAK$[,IV9-?74R>9$R>HKQ;XG^%MEC
M)<HF2<G@4 >&>&]3>RU2$DX4-S7U;X6\6:?<Z9!$LREPHR,U\>212P2ME&4@
M^E;_ (;\4SZ1<!FE8@'IF@#[2AF29=R'(K%\0:2FHPL&7/%>/Z+\9%7;"QKT
M_P />+K?60-SJ,^IH XK3?!AM?$8N%BP >N*]@@79 B^@IB+;L=RA2?45/0
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M@HHHIC"BBB@ HHHH *BN/]2WTJ6HKC_4M]* /#_BFQ^R/5CX2#_0!5?XI_\
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M7C->9Z?&]]K$<;$G<]?47@#PJNG6L-P!RP!H ]!MX%@C"J,<5-1VHH ****
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M0AG5,@-FOJ[1(/(TN%".0M>5?"+1A_9RNZ<@=Q7L<:;$"CM0 ^BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** ./\8^'EU>W9=F[CTKYX\5?#^]M)WE6,
MA![5];%01R*QM8T&'4[=HV4<^U 'Q@EQ>Z4Q6-F7!JY%XHU8G:LS_G7T'>?!
MVSN9"Q Y-5X_@I9(V<"@#Q6WM]9UK WLV:[?PC\-+P3&6[B)4\\BO6='^'MM
MI97:HX]J[6"UCAA"!0,"@#Y3\:^#9X-1801X7V%=#\,-!NH+G)!ZU[9JOA2#
M492[*.?:GZ-X8ATI]R 4 :^G1M';*K=<5<I ,#%+0 4444 %%%% #7^X<>E<
M-XF@N[E'2(FNZ/(Q51[)7?)%9U(\R(G'F5CP]O"NI2N2P)YIQ\)7^.%/Y5[=
M]@C_ +HH^PI_=%<CPS;N<4L'=GB*^$;[;RIS]*8/">H(?NG\J]Q^PI_=%(UA
M&W\(H^JWW)^I(\1/A*_<<*?RKIO"WA26!\W*9Y[BO24L8U_A%3I"J= *J&$2
M9<,&DR*SMT@A"*,8JU28I:[$K*QVQ5E8****904444 %9NL0M-:E5ZUI4UUW
M#!I/5":NK'C&N>&+VXN"R XS6:/"=^!]T_E7N+6:-U44S[!'_=%<<\*I.YQU
M,'&;/$?^$3OS_"<_2E7PE?C[RG\J]M^P1YSM%.:QC(^Z*2P:1G]1BCPYO"M^
M#PIQ]*5/"5^S#Y3^5>VG3H\?=%*EA&O\(I/!H3P*N>>^&O"\MO<JTR?I7I-O
M D" *,<4J0JG0"I:ZJ5)05CLI4E!6"BBBM38**** $I:** "BBB@ HHHH Y7
MQL+HZ1)]E)#XXQ7@5Q#XH:5P)I,$U]/W=LMU$48=:Q#X8@)SM'Y4 ?,MUX;U
MZ^_UI=LU+9>'?$%@NV!G4>U?2X\,P#^$?E3O^$<@_N#\J!L^>(K?Q4LBYEDQ
MGWKWOP*MVNCH+LDOCO5S_A&X,YV#\JU[2V6UCV**!%BBBB@ HHHH 9)&LJ%6
M&0:\O^(W@S^TK9C;1?-CL*]3IDL2R*0P!S0!\J^%O#%UIGBR(2*1AO2OJ6Q&
M+*(?[(KGV\)0'4Q=@ $'-=-&FR-5]!0 IZ5XS\2UUDWO^@R,%SVKV>LG4-&C
MO7W, : /F>;3_$]PF'DD(K%N?!6K7,FZ16)^E?5 \-0 ?<'Y4T^&8,YVK^5
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MC.,YZ5ZYI'@JWTW;M5>/:NJC@2- H4<4 4M&M3:62QD8P*T)$61"C#(-.HH
M\Q^(/@2'4K%VM81YI'4"O ;_ ,"ZGI<C.RD;3Z5]ELH88(S7.ZQX8@U,,&4<
M^U 'R.->U;33L65QMIQ\::S(-IG?\Z]^N_@Y9W,C,0.:JK\$;)3GB@#PM(M3
MU]@&9FS7;>#?AK>M?)-<1$QY[BO7-(^&%KIK J!Q[5W5CI\=G"$51Q[4 4-
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MN+1110,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH .U>*?%W=DXKVOM7C'
MQ:1V)VC- '@EH?\ B9\^M?3GPM(.EC'I7S);Q2?VF?E/6OIKX5JRZ6-PQQ0!
MZ/1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 ,D;;&S>@KQGXE^*X1:36F[YN1UKUK5+I(+63<V/E-?)_
MQ$NY9]=E"9*DT <UIEJUYK",!D%Z^MO ^EP0:' X0!MHYQ7@WPV\.?VA*LCI
MT.>E?2^CVPM+!(@.@H T**** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I,4M% !30>:=28H 6BD/2
MD&<T .HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 0
MBEHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH 0BC%+10*PF*,4M% 6"BBB@84444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4F:6B@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
=BB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
